+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Geography & Life Sciences: Chapter 10732

Chapter 10732 provides bibliographic information on scholary research in geography and in the life sciences.

HIV-1 DNA vaccines and chemokines. Vaccine 17(SUPPL 2): S53-S64, Oct 1

HIV-1 gag proteins: diverse functions in the virus life cycle. Virology 251(1): 1-15

HIV-1 Gp120 protein modulates corticotropin releasing factor synthesis and release via the stimulation of its mRNA from the rat hypothalamus in vitro: Involvement of inducible nitric oxide synthase. Journal of Neuroimmunology 118(2): 268-276, August 30

HIV-1 ICD p24 antigen detection in Ugandan infants: Use in early diagnosis of infection and as a marker of disease progression. Journal of Medical Virology 62(4): 426-434, December

HIV-1 LTR C/EBP binding site sequence configurations preferentially encountered in brain lead to enhanced C/EBP factor binding and increased LTR-specific activity. Journal of Neurovirology 7(3): 235-249

HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell culture. Nucleic Acids Research 28(21): 4059-4067

HIV-1 NEF protein causes death in stressed yeast cells due to determinants near the N-terminus and elsewhere in NEF. Biochemistry & Molecular Biology International 46(2): 277-286, Oct

HIV-1 Nef activates STAT1 in human monocytes/macrophages through the release of soluble factors. Blood 98(9): 2752-2761

HIV-1 Nef associated PAK and PI3-kinases stimulate Akt-independent Bad-phosphorylation to induce anti-apoptotic signals. Nature Medicine 7(11): 1217-1224

HIV-1 Nef control of cell signalling molecules: Multiple strategies to promote virus replication. Journal of Biosciences (Bangalore) 28(3): 323-335, April

HIV-1 Nef downregulates MHC-I by a PACS-1- and PI3K-Regulated ARF6 endocytic pathway. Cell 111(6): 853-866, December 13

HIV-1 Nef interacts with inositol trisphosphate receptor to activate calcium signaling in T cells. Journal of Experimental Medicine 195(8): 1023-1032

HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages. Nature Medicine 5(9): 997-103

HIV-1 Nef plays an essential role in two independent processes in CD4 down-regulation: dissociation of the CD4-p56(lck) complex and targeting of CD4 to lysosomes. Virology 257(1): 208-219

HIV-1 Nef promotes survival of myeloid cells by a Stat3-dependent pathway. Journal of Biological Chemistry 276(27): 25605-25611

HIV-1 Nef protein binds to the cellular protein PACS-1 to downregulate class I major histocompatibility complexes. Nature Cell Biology 2(3): 163-167

HIV-1 Nef stabilizes the association of adaptor protein complexes with membranes. Journal of Biological Chemistry 278(10): 8725-8732

HIV-1 Nef-induced upregulation of DC-SIGN in dendritic cells promotes lymphocyte clustering and viral spread. Immunity 16(1): 145-155, January

HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress. Experimental Neurology 154(2): 276-288

HIV-1 RNA detection in cervico-vaginal secretions form HIV-1 seropositive women: Clinical and immunological correlates. Giornale Italiano di Malattie Infettive 5(3): 152-157, May-June

HIV-1 RNA dimerization initiation site is structurally similar to the ribosomal A site and binds aminoglycoside antibiotics. Journal of Biological Chemistry 278(4): 2723-2730

HIV-1 RNA levels and development of clinical disease in two different adolescent populations. Journal of Acquired Immune Deficiency Syndromes 26(5): 449-457

HIV-1 RNA load in needles/syringes from shooting galleries in Miami: A preliminary laboratory report. Drug & Alcohol Dependence 58(1-2): 153-157, Feb 1

HIV-1 RNA response to antiretroviral treatment in 1280 participants in the Delta Trial: an extended virology study. Aids 13(1): 57-65

HIV-1 RNA viral load monitoring in HIV-infected drug users on antiretroviral therapy: relationship with outpatient care patterns. Journal of Acquired Immune Deficiency Syndromes 29(3): 270-274

HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy. Aids 15(17): 2251-2257

HIV-1 Rev promotes the nuclear export of unspliced and singly spliced RNAs in a mammalian cell-free export system. Journal of Biomedical Science 6(3): 194-205, May-June

HIV-1 TAR RNA enhances the interaction between Tat and cyclin T1. Journal of Biological Chemistry 275(44): 34314-9

HIV-1 TAR as anchoring site for optimized catalytic RNAs. Biological Chemistry 384(3): 343-350

HIV-1 TAT-mediated protein transduction and subcellular localization using novel expression vectors. FEBS Letters 532(1-2): 36-44, 4 December

Hiv-1 Tat can substantially enhance the capacity of NIK to induce IkappaB degradation. Biochemical and Biophysical Research Communications 286(3): 587-594

HIV-1 Tat increases endothelial solute permeability through tyrosine kinase and mitogen-activated protein kinase-dependent pathways. Aids 14(5): 475-482

HIV-1 Tat interaction with RNA polymerase II C-terminal domain (CTD) and a dynamic association with CDK2 induce CTD phosphorylation and transcription from HIV-1 promoter. Journal of Biological Chemistry 277(37): 33922-9

HIV-1 Tat mutants in the cysteine-rich region downregulate HLA class II expression in T lymphocytic and macrophage cell lines. European Journal of Immunology 30(1): 19-28

HIV-1 Tat neurotoxicity is prevented by matrix metalloproteinase inhibitors. Annals of Neurology 49(2): 230-241, February

HIV-1 Tat promotes monocyte chemoattractant protein-1 secretion followed by transmigration of monocytes. Blood 97(2): 352-358

HIV-1 Tat protects CD4+ Jurkat T lymphoblastoid cells from apoptosis mediated by TNF-related apoptosis-inducing ligand. Cellular Immunology 207(2): 89-99

HIV-1 Tat protein alters tight junction protein expression and distribution in cultured brain endothelial cells. Journal of Neuroscience Research 74(2): 255-265

HIV-1 Tat protein and endothelium: From protein/cell interaction to AIDS-associated pathologies. Angiogenesis 5(3): 141-151

HIV-1 Tat protein induces interleukin-10 in human peripheral blood monocytes: involvement of protein kinase C-betaII and -delta. Faseb Journal 16(6): 546-554

HIV-1 Tat protein interacts with mammalian capping enzyme and stimulates capping of TAR RNA. Journal of Biological Chemistry 276(16): 12959-12966

HIV-1 Tat protein is poly(ADP-ribosyl)ated in vitro. Biochemical and Biophysical Research Communications 261(1): 90-94

HIV-1 Tat protein upregulates inflammatory mediators and induces monocyte invasion into the brain. Molecular & Cellular Neuroscience 24(1): 224-237, September

HIV-1 Tat targets microtubules to induce apoptosis, a process promoted by the pro-apoptotic Bcl-2 relative Bim. EMBO (European Molecular Biology Organization) Journal 21(24): 6801-6810, December 16

HIV-1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity. Journal of Neurochemistry 78(3): 457-467, August

HIV-1 tat transcriptional activity is regulated by acetylation. Embo Journal 18(21): 6106-6118

HIV-1 Tat-associated RNA polymerase C-terminal domain kinase, CDK2, phosphorylates CDK7 and stimulates Tat-mediated transcription. Biochemical Journal 364(Pt 3): 649-657

HIV-1 Tat-based vaccines: from basic science to clinical trials. Dna and Cell Biology 21(9): 599-610

HIV-1 Tat-mediated apoptosis in human brain microvascular endothelial cells. Journal of Immunology 170(5): 2629-2637

HIV-1 Tat-mediated inhibition of the tyrosine hydroxylase gene expression in dopaminergic neuronal cells. Journal of Biological Chemistry 275(6): 4159-4165

HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Molecular Cell 12(3): 591-601, September

HIV-1 Vif-derived peptide inhibits drug-resistant HIV proteases. Biochemical and Biophysical Research Communications 292(4): 832-840

HIV-1 Vpr binding to HIV-1 LTR C/EBP cis-acting elements and adjacent regions is sequence-specific. Biomedicine & Pharmacotherapy 57(1): 41-48, January

HIV-1 Vpr enhances viral burden by facilitating infection of tissue macrophages but not nondividing CD4+ T cells. Journal of Experimental Medicine 194(10): 1407-1419

HIV-1 Vpr induces apoptosis through caspase 9 in T cells and peripheral blood mononuclear cells. Journal of Biological Chemistry 277(40): 37820-37831

HIV-1 VPR modulates cell cycle G2/M transition through an alternative cellular mechanism other than the classic mitotic checkpoints. Frontiers in Bioscience 7: D349-D357

HIV-1 actively replicates in naive CD4+ T cells residing within human lymphoid tissues. Immunity 15(4): 671-682, October

HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nature Medicine 7(12): 1313-1319

HIV-1 and its causal relationship to immunosuppression and nervous system disease in AIDS: a review. Human Pathology 31(10): 1274-1298

HIV-1 and other sexually transmitted infections in a cohort of female sex workers in Chiang Rai, Thailand. Sexually Transmitted Infections 75(1): 30-35

HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers. Lancet 358(9294): 1687-1693

HIV-1 and the brain: Connections between HIV-1-associated dementia, neuropathology and neuroimmunology. Microbes & Infection 4(3): 301-308, March

HIV-1 antiviral activity of recombinant natural killer cell enhancing factors, NKEF-A and NKEF-B, members of the peroxiredoxin family. Journal of Biological Chemistry 278(3): 1569-1574

HIV-1 associated encephalopathy and myelopathy. Journal of Neurology 249(8): 1132-1136, August

HIV-1 capsid protein forms spherical (immature-like) and tubular (mature-like) particles in vitro: structure switching by pH-induced conformational changes. Biophysical Journal 81(1): 586-594

HIV-1 co-receptor CCR5 and CCR2 mutations among Greeks. FEMS Immunology & Medical Microbiology 28(1): 87-89, May

HIV-1 co-receptor expression on trophoblastic cells from early placentas and permissivity to infection by several HIV-1 primary isolates. Clinical & Experimental Immunology 119(3): 486-492, March

HIV-1 coat glycoprotein gp120 induces apoptosis in rat brain neocortex by deranging the arachidonate cascade in favor of prostanoids. Journal of Neurochemistry 75(1): 196-203, July

HIV-1 coat protein gp120 stimulates interleukin-1beta secretion from human neuroblastoma cells: evidence for a role in the mechanism of cell death. British Journal of Pharmacology 134(6): 1344-1350

HIV-1 disease progression in women: role of the viral phenotype of the HIV-positive steady partner. Aids 13(13): 1801-1802

HIV-1 diversity in Brazil: Genetic, biologic, and immunologic characterization of HIV-1 strains in three potential HIV vaccine evaluation sites. JAIDS Journal of Acquired Immune Deficiency Syndromes 23(2): 184-193, Feb 1

HIV-1 diversity in France, 1996-1998. AIDS (Hagerstown) 14(3): 289-296, Feb

HIV-1 drug resistance in newly infected individuals. JAMA 282(12): 1135-1141

HIV-1 dynamics in children. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 20(5): 468-473

HIV-1 dynamics in haemodialysis patients. Aids 16(9): 1301-1303

HIV-1 dynamics revisited: biphasic decay by cytotoxic T lymphocyte killing?. Proceedings. Biological Sciences 267(1450): 1347-1354

HIV-1 encoded virus protein U (Vpu) solution structure of the 41-62 hydrophilic region containing the phosphorylated sites Ser52 and Ser56. International Journal of Biological Macromolecules 30(1): 23-40

HIV-1 entry into T-cells is not dependent on CD4 and CCR5 localization to sphingolipid-enriched, detergent-resistant, raft membrane domains. Journal of Biological Chemistry 278(5): 3153-3161

HIV-1 envelope is a neutral antagonist to CXCR4 in T-cells. Biochemical and Biophysical Research Communications 280(4): 1003-1007

HIV-1 envelope protein gp41 modulates expression of interleukin-10 and chemokine receptors on monocytes, astrocytes and neurones. Aids 14(6): 629-636

HIV-1 envelope proteins complete their folding into six-helix bundles immediately after fusion pore formation. Molecular Biology of the Cell 14(3): 926-938

HIV-1 epidemic among female bar and hotel workers in northern Tanzania: risk factors and opportunities for prevention. Journal of Acquired Immune Deficiency Syndromes 29(4): 409-417

HIV-1 evolution under pressure of protease inhibitors: Climbing the stairs of viral fitness. Journal of Biomedical Science 6(5): 298-305, Sept -Oct

HIV-1 evolves into a nonsyncytium-inducing virus upon prolonged culture in vitro. Virology 263(1): 55-69

HIV-1 exposed dendritic cells show increased pro-inflammatory cytokine production but reduced IL-1ra following lipopolysaccharide stimulation. Aids 13(15): 2013-2021

HIV-1 expression induces cyclin D1 expression and pRb phosphorylation in infected podocytes: Cell-cycle mechanisms contributing to the proliferative phenotype in HIV-associated nephropathy. BMC Microbiology 2(26 Cited October 28, ), September 19

HIV-1 genetic diversity in Galicia Spain: BG intersubtype recombinant viruses circulating among injecting drug users. Aids 15(4): 509-516

HIV-1 genetic diversity in Western Brittany, France. FEMS Immunology & Medical Microbiology 34(1): 65-71, 6 September

HIV-1 genetic variability in Cameroon. Aids 14(12): 1862-1864

HIV-1 genotype and phenotype correlate with virological response to abacavir, amprenavir and efavirenz in treatment-experienced patients. Aids 16(3): 387-396

HIV-1 genotypic resistance patterns predict response to saquinavir-ritonavir therapy in patients in whom previous protease inhibitor therapy had failed. Annals of Internal Medicine 131(11): 813-821

HIV-1 genotypic zidovudine drug resistance and the risk of maternal-infant transmission in the Women and Infants Transmission Study. AIDS (Hagerstown) 14(3): 263-271, Feb

HIV-1 glycoprotein 120 induces the MMP-9 cytopathogenic factor production that is abolished by inhibition of the p38 mitogen-activated protein kinase signaling pathway. Blood 98(3): 541-547

HIV-1 gp120 and chemokine activation of Pyk2 and mitogen-activated protein kinases in primary macrophages mediated by calcium-dependent, pertussis toxin-insensitive chemokine receptor signaling. Blood 98(10): 2909-2916

HIV-1 gp120 chemokine receptor-mediated signaling in human macrophages. Immunologic Research 27(2-3): 261-276

HIV-1 gp120 envelope protein modulates proliferation of human glomerular epithelial cells. Journal of Cellular Biochemistry 76(1): 61-70

HIV-1 gp120 proteins and gp160 peptides are toxic to brain endothelial cells and neurons: possible pathway for HIV entry into the brain and HIV-associated dementia. Journal of Neuropathology and Experimental Neurology 61(11): 992-1000

HIV-1 gp160 decreases the K+ voltage-gated current from Jurkat E6.1 T cells by up-phosphorylation. FEBS Letters 443(2): 187-191, Jan 25

HIV-1 gp41 and type I interferon: sequence homology and biological as well as clinical implications. Immunologic Research 22(1): 61-66

HIV-1 gp41 by N-domain binds the potential receptor protein P45. International Archives of Allergy and Immunology 121(3): 253-257

HIV-1 gp41 envelope residues 650-685 exposed on native virus act as a lectin to bind epithelial cell galactosyl ceramide. Journal of Biological Chemistry 277(28): 25649-25659

HIV-1 group N among HIV-1-seropositive individuals in Cameroon. Aids 14(16): 2623-2625

HIV-1 in peripheral blood monocytes: an underrated viral source. Journal of Antimicrobial ChemoTherapy 50(3): 309-311

HIV-1 in placentas of untreated HIV-1-infected women in relation to viral transmission, infectious HIV-1 and RNA load in plasma. Scandinavian Journal of Infectious Diseases 33(1): 27-32

HIV-1 in semen: Determination of proviral and viral titres compared to blood, and quantification of semen leukocyte populations. Journal of Medical Virology 59(3): 356-363, Nov

HIV-1 incidence among male workers at a sugar estate in rural Malawi. Journal of Acquired Immune Deficiency Syndromes 27(2): 202-208

HIV-1 incidence among opiate users in northern Thailand. American Journal of Epidemiology 149(6): 558-564

HIV-1 induces renal epithelial dedifferentiation in a transgenic model of HIV-associated nephropathy. Kidney International 58(1): 173-181

HIV-1 infectability of CD4+ lymphocytes with relation to beta-chemokines and the CCR5 coreceptor. Immunology Letters 66(1-3): 71-75

HIV-1 infection. Journal of Allergy & Clinical Immunology 111(2 Supplement): S582-S592, February

HIV-1 infection among civilian applicants for US military service, 1985 to 2000: epidemiology and geography. Journal of Acquired Immune Deficiency Syndromes 32(2): 215-222

HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Proceedings of the National Academy of Sciences of the United States of America 99(21): 13795-13800

HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: a prospective cohort study. Lancet 359(9301): 108-113

HIV-1 infection impairs cell cycle progression of CD4(+) T cells without affecting early activation responses. Journal of Clinical Investigation 108(5): 757-764

HIV-1 infection in a heterosexual man homozygous for CCR-5 delta32. Aids 13(4): 529-530

HIV-1 infection in individuals with the CCR5-Delta32/Delta32 genotype: acquisition of syncytium-inducing virus at seroconversion. Journal of Acquired Immune Deficiency Syndromes 29(3): 307-313

HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries?. Aids 16(4): 597-603

HIV-1 infection induces differentiation of immature neural cells through autocrine tumor necrosis factor and nitric oxide production. Virology 261(2): 193-204

HIV-1 infection is facilitated in T cells by decreasing p56lck protein tyrosine kinase activity. Clinical & Experimental Immunology 133(1): 78-90, July

HIV-1 infection of primary effusion lymphoma cell line triggers Kaposi's sarcoma-associated herpesvirus (KSHV) reactivation. International Journal of Cancer 97(6): 791-795

HIV-1 infection requires a functional integrase NLS. Molecular Cell 7(5): 1025-1035, May

HIV-1 infection transmitted by serum droplets into the eye: a case report. Aids 14(2): 206-207

HIV-1 infection-associated risk factors among sexually transmitted disease patients in Athens, Greece: 1990 to 1996. Sexually Transmitted Diseases 27(5): 259-265

HIV-1 infectivity and host range modification by cathepsin D present in human vaginal secretions. Aids 13(3): 333-339

HIV-1 infects and alters immune function of a monocyte subset expressing low CD14 surface phenotype. Viral Immunology 13(1): 19-26

HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells. Journal of Biological Chemistry 278(1): 372-381

HIV-1 integrase interaction with U3 and U5 terminal sequences in vitro defined using substrates with random sequences. Journal of Biological Chemistry 277(21): 18357-18364

HIV-1 integrase interacts with yeast microtubule-associated proteins. Biochimica et Biophysica Acta 1575(1-3): 40-48, 3 May

HIV-1 integrase: The next target for AIDS therapy?. Pathologie Biologie 49(3): 237-246, Avril

HIV-1 kills renal tubular epithelial cells in vitro by triggering an apoptotic pathway involving caspase activation and Fas upregulation. Journal of Clinical Investigation 102(12): 2041-2049

HIV-1 long terminal repeat modulation by glucocorticoids in monocytic and lymphocytic cell lines. Virus Research 64(1): 87-94, Oct

HIV-1 matrix protein p17 enhances the proliferative activity of natural killer cells and increases their ability to secrete proinflammatory cytokines. British Journal of Haematology 120(2): 337-343, January

HIV-1 multi-dideoxynucleoside resistance mutation (Q151M): prevalence, associated resistance mutations and response to antiretroviral salvage treatment. Microbios 106(414): 137-145

HIV-1 Nef induces proliferation and anchorage-independent growth in podocytes. Journal of the American Society of Nephrology 13(7): 1806-1815

HIV-1 p24 antigen is a significant inverse correlate of CD4 T-cell change in patients with suppressed viremia under long-term antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes 33(3): 292-299

HIV-1 p24 antigen testing in blood banks: results from Saudi Arabia. British Journal of Biomedical Science 60(2): 102-104

HIV-1 p55Gag encoded in the lysosome-associated membrane protein-1 as a DNA plasmid vaccine chimera is highly expressed, traffics to the major histocompatibility class II compartment, and elicits enhanced immune responses. Journal of Biological Chemistry 278(39): 37926-37936

HIV-1 penetrates coronary artery endothelial cells by transcytosis. Molecular Medicine 7(3): 169-176

HIV-1 pharmacoresistance: clinical and therapeutic implications. Journal of Biological Regulators and Homeostatic Agents 13(3): 163-171

HIV-1 phenotypic susceptibility to lopinavir (LPV) and genotypic analysis in LPV/r-naive subjects with prior protease inhibitor experience. Journal of Acquired Immune Deficiency Syndromes 33(4): 439-447

HIV-1 plasma viremia not increased in patients receiving highly active antiretroviral therapy after influenza vaccination. European Journal of Clinical Microbiology & Infectious Diseases 20(1): 46-48, January

HIV-1 polymorphism: a challenge for vaccine development - a review. Memorias do Instituto Oswaldo Cruz 97(2): 143-150

HIV-1 preintegration complexes preferentially integrate into longer target DNA molecules in solution as detected by a sensitive, polymerase chain reaction-based integration assay. Journal of Biological Chemistry 276(50): 46946-46952

HIV-1 prevalence, HIV-1 subtypes and risk factors among fishermen in the Gulf of Thailand and the Andaman Sea. Aids 14(8): 1027-1034

HIV-1 protease and reverse transcriptase mutation patterns responsible for discordances between genotypic drug resistance interpretation algorithms. Journal of Acquired Immune Deficiency Syndromes 33(1): 8-14

HIV-1 protease inhibitor-associated partial lipodystrophy: clinicopathologic review of 14 cases. Journal of the American Academy of Dermatology 42(2 Pt 1): 193-198

HIV-1 protease inhibitors. Clinical Infectious Diseases 30(Supplement 2): S160-S170, June

HIV-1 protease inhibitors decrease proliferation and induce differentiation of human myelocytic leukemia cells. Blood 96(10): 3553-3559

HIV-1 protease inhibitors induce an increase of triglyceride level in HIV-infected men without modification of insulin sensitivity: a longitudinal study. Hormone and Metabolic Research 32(9): 367-372

HIV-1 protease inhibitors may interfere with the ubiquitous intracellular proteases. Annals of Internal Medicine 135(9): 840-840

HIV-1 protease tethered heterodimer-pepstatin-A complex: NMR characterization. Current Science (Bangalore) 79(12): 1684-1695, 25 December

HIV-1 protease variants from 100-fold drug resistant clinical isolates: Expression, purification, and crystallization. Protein Expression & Purification 28(1): 165-172, March

HIV-1 protein Tat potentiation of methamphetamine-induced decreases in evoked overflow of dopamine in the striatum of the rat. Brain Research 984(1-2): 133-142, 12 September

HIV-1 protein Tat reduces the glutamate-induced intracellular Ca2+ increase in cultured cortical astrocytes. European Journal of Neuroscience 14(11): 1793-1799

HIV-1 protein Vpr suppresses IL-12 production from human monocytes by enhancing glucocorticoid action: potential implications of Vpr coactivator activity for the innate and cellular immunity deficits observed in HIV-1 infection. Journal of Immunology 169(11): 6361-6368

HIV-1 reactivation in resting peripheral blood mononuclear cells of infected adults upon in vitro CD4 cross-linking by ligands of the CDR2-loop in extracellular domain 1. Journal of Acquired Immune Deficiency Syndromes 21(1): 9-19

HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment. AIDS (Hagerstown) 13(6): 677-683, April 16

HIV-1 recombinant strain causing epidemic among injection-practicing drug addicts in Kaliningrad. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 0(1): 47-49, Jan -Feb

HIV-1 related ischaemic trochlear nerve palsy. Journal of Neurology 250(1): 108-109

HIV-1 replication. Somatic Cell & Molecular Genetics 26(1-6): 13-33, November

HIV-1 replication increases HIV-specific CD4+ T cell frequencies but limits proliferative capacity in chronically infected children. Journal of Immunology 170(11): 5786-5792

HIV-1 replication inhibitors of the styrylquinoline class: Incorporation of a masked diketo acid pharmacophore. Tetrahedron Letters 42(46): 8189-8192, 12 November

HIV-1 resistance genotyping by sequencing produces inconsistent results for mixed viral populations. Aids 14(10): 1473-1475

HIV-1 resistance to the gp41-dependent fusion inhibitor C-34. Antiviral Research 59(2): 137-142, July

HIV-1 reverse transcriptase (RT) genotype and susceptibility to RT inhibitors during abacavir monotherapy and combination therapy. Aids 14(2): 163-171

HIV-1 reverse transcriptase and integrase enzymes physically interact and inhibit each other. FEBS Letters 507(1): 39-44, 19 October

HIV-1 reverse transcriptase interaction with model RNA-DNA duplexes. Analytical Biochemistry 291(2): 198-206

HIV-1 reverse transcriptase is phosphorylated in vitro and in a cellular system. International Journal of Biochemistry & Cell Biology 31(12): 1443-1452, Dec

HIV-1 reverse transcriptase sequence in plasma and cerebrospinal fluid of patients with AIDS dementia complex treated with Abacavir. Aids 15(6): 747-751

HIV-1 reverse transcriptase-pseudoknot RNA aptamer interaction has a binding affinity in the low picomolar range coupled with high specificity. Journal of Biological Chemistry 275(24): 18271-8

HIV-1 reverse transcription: a brief overview focused on structure-function relationships among molecules involved in initiation of the reaction. Archives of Biochemistry and Biophysics 365(2): 199-210

HIV-1 seroconversion in United States Army active duty personnel, 1985-1999. Aids 15(12): 1569-1574

HIV-1 seroprevalence among childbearing women in northern Thailand: monitoring a rapidly evolving epidemic. Aids 13(4): 509-515

HIV-1 seroprevalence in Zambian patients with acute diarrhea: a community-based study. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 20(2): 160-163

HIV-1 seroprevalence, risk factors, and preventive behaviors among women in northern Thailand. Journal of Acquired Immune Deficiency Syndromes 25(4): 353-359

HIV-1 strains from a cohort of American subjects reveal the presence of a V2 region extension unique to slow progressors and non-progressors. Aids 14(3): 213-223

HIV-1 Subtype A, D, G, AG and unclassified sequences identified in South Africa. Aids Research and Human Retroviruses 18(9): 681-683

HIV-1 subtype C as a major determinant of the global AIDS epidemic. South African Journal of Science 96(6): 339-342, June

HIV-1 subtype C reverse transcriptase and protease genotypes in Zimbabwean patients failing antiretroviral therapy. Aids Research and Human Retroviruses 18(18): 1407-1413

HIV-1 subtype C reverse transcriptase sequences from drug-naive pregnant women in South Africa. Aids Research and Human Retroviruses 18(8): 605-610

HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDS. Aids 13(11): 1305-1311

HIV-1 subtype G and BG recombinant viruses in Spanish natives: evidence of characteristic mutations in reverse transcriptase and protease. Aids 15(14): 1907-1910

HIV-1 subtype J recombinant viruses in Spain. Aids Research and Human Retroviruses 18(7): 523-529

HIV-1 subtypes among blood donors from Rio de Janeiro, Brazil. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 20(1): 60-66

HIV-1 subtypes and circulating recombinant forms (CRFs) in Northern Greece. Virus Research 85(1): 85-93

HIV-1 subtypes and the HIV epidemics in four cities in sub-Saharan Africa. Aids 15 Suppl 4: S109-S116

HIV-1 subtypes in Denmark. Scandinavian Journal of Infectious Diseases 33(9): 697-701

HIV-1 subtypes in Luxembourg, 1983-2000. Aids 16(18): 2461-2467

HIV-1 subtypes in Yugoslavia. Aids Research and Human Retroviruses 18(7): 519-522

HIV-1 Tat causes apoptotic death and calcium homeostasis alterations in rat neurons. Biochemical and Biophysical Research Communications 288(2): 301-308

HIV-1 tat induced apoptosis of T-cells is not mediated by TGF-beta. Medical Oncology 17(3): 211-217

HIV-1 tat protein induces the production of interleukin-8 by human brain-derived endothelial cells. Journal of Neuroimmunology 94(1-2): 28-39, Feb 1

HIV-1 Tat protein-mediated transactivation of the HIV-1 long terminal repeat promoter is potentiated by a novel nuclear Tat-interacting protein of 110 kDa, Tip110. Journal of Biological Chemistry 277(26): 23854-23863

HIV-1 testing in pregnancy: acceptability and correlates of return for test results. Aids 14(10): 1468-1470

HIV-1 trans-activating (Tat) protein: Both a target and a tool in therapeutic approaches. Biochemical Pharmacology 58(10): 1521-1528

HIV-1 transcription and virus production are both accentuated by the proinflammatory myeloid-related proteins in human CD4+ T lymphocytes. Journal of Immunology 169(6): 3307-3313

HIV-1 vaccination administered intramuscularly can induce both systemic and mucosal T cell immunity in HIV-1-uninfected individuals. Journal of Immunology 171(2): 1094-1101

HIV-1 vaccine-induced immune responses which correlate with protection from SHIV infection: Compiled preclinical efficacy data from trials with ten different HIV-1 vaccine candidates. Immunology Letters 66(1-3): 189-195, March

HIV-1 variation diminishes CD4 T lymphocyte recognition. Journal of Experimental Medicine 188(10): 1785-1793

HIV-1 vector systems. Somatic Cell & Molecular Genetics 26(1-6): 51-81, November

HIV-1 viral load and elevated serum alpha(1)-antichymotrypsin are independent predictors of body composition in pregnant Zimbabwean women. Journal of Nutrition 132(12): 3747-3753

HIV-1 virions produced from replicating peripheral blood lymphocytes are more infectious than those from nonproliferating macrophages due to higher levels of intravirion reverse transcripts: implications for pathogenesis and transmission. Virology 253(1): 10-16

HIV-1, HAART and bone metabolism. New Microbiologica 25(3): 375-384

HIV-1, NFAT, and cyclosporin: immunosuppression for the immunosuppressed?. Dna and Cell Biology 20(12): 761-767

HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet (North American Edition) 360(9349): 1921-1926

HIV-1-associated dementia: a metabolic encephalopathy perpetrated by virus-infected and immune-competent mononuclear phagocytes. Journal of Acquired Immune Deficiency Syndromes 31 Suppl 2: S43-S54

HIV-1-induced neuronal injury in the developing brain. Journal of Leukocyte Biology 65(4): 453-457

HIV-1-induced perturbations of glycosphingolipid metabolism are cell-specific and can be detected at early stages of HIV-1 infection. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 19(3): 221-229

HIV-1-related encephalopathy in infants compared with children and adults. Neurology 54(5): 1089-1095, March 14

HIV-1-related pleural tuberculosis: elevated production of IFN-gamma, but failure of immunity to Mycobacterium tuberculosis. Aids 15(4): 467-475

HIV-1-related spontaneous episodic hypothermia. Neurology 61(3): 418-419

HIV-1-Specific CD4 helper function in persons with chronic HIV-1 infection on antiviral drug therapy as measured by ELISPOT after treatment with an inactivated, gp120-depleted HIV-1 in incomplete Freund's adjuvant. Journal of Acquired Immune Deficiency Syndromes 24(3): 264-269

HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression. Nature Medicine 5(5): 518-525

HIV-1-specific CD8 T cell responses in a pediatric slow progressor infected as a premature neonate. Aids 16(15): 2085-2087

HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy. Journal of Clinical Investigation 104(6): R13-R18

HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers. Aids 13(1): 23-29

HIV-(1/2) indeterminate western blot results: follow-up of asymptomatic blood donors in belo horizonte, minas gerais, brazil. Revista do Instituto de Medicina Tropical de Sao Paulo 41(3): 155-158

HIV-1/AIDS and maternal and child health in Africa. Lancet 359(9323): 2097-2104

HIV-1: a case of RT67 deletion in a multi-treated non responder patient. New Microbiologica 25(1): 83-88

HIV-1(Lai) genomic RNA: combined used of NMR and molecular dynamics simulation for studying the structure and internal dynamics of a mutated SL1 hairpin. European Biophysics Journal 31(7): 521-531

HIV-1MN recombinant glycoprotein 160 vaccine-induced cellular and humoral immunity boosted by HIV-1MN recombinant glycoprotein 120 vaccine. AIDS Research & Human Retroviruses 15(2): 115-132, Jan 20

HIV-2 and SIV nef proteins target different Src family SH3 domains than does HIV-1 Nef because of a triple amino acid substitution. Journal of Biological Chemistry 275(6): 4171-4176

HIV-2 and SIV vector systems. Somatic Cell & Molecular Genetics 26(1-6): 83-98, November

HIV-2 derived lentiviral vectors: gene transfer in Parkinson's and Fabry disease models in vitro. Journal of Medical Virology 71(2): 173-182

HIV-2 does not protect against HIV-1 infection in a rural community in Guinea-Bissau. Aids 15(17): 2303-2310

HIV-2 protease is inactivated after oxidation at the dimer interface and activity can be partly restored with methionine sulphoxide reductase. Biochemical Journal 346 Pt 2: 305-311

HIV-2 transmembrane protein gp36 binds to the putative cellular receptor proteins P45 and P62. Immunobiology 201(3-4): 317-322

HIV-AIDS prevention efforts deserved greater mention. BMJ 325(7354): 45-46

HIV-Infektion, HAART (hoch aktive antiretrovirale Therapie), und Hyperlipidaemie. DMW Deutsche Medizinische Wochenschrift 128(19): 1051-1054

HIV-Nef enhances interleukin-2 production and phosphatidylinositol 3-kinase activity in a human T cell line. Aids 14(12): 1701-1707

HIV-Patienten mit psychiatrischen Krankheiten: Behandlungsstrategien und Medikamenteninteraktionen. Nervenarzt 72(3): 204-215

HIV-Tat protein induces oxidative and inflammatory pathways in brain endothelium. Journal of Neurochemistry 84(1): 169-179, January

HIV-associated Guillain-Barre syndrome. Journal of the Neurological Sciences 208(1-2): 39-42, April 15

HIV-associated PML presenting as epilepsia partialis continua. Journal of the Neurological Sciences 161(2): 180-184, Dec 11

HIV-associated Waldeyer's ring lymphoid hyperplasias: Characterization of multinucleated giant cells and the role of Epstein-Barr virus. Human Pathology 30(11): 1383-1388, Nov

HIV-associated bacteremia: how it has changed in the highly active antiretroviral therapy (HAART) era. Journal of Acquired Immune Deficiency Syndromes 23(2): 145-151

HIV-associated cognitive impairment before and after the advent of combination therapy. Journal of Neurovirology 8(2): 136-142

HIV-associated coronary artery disease. Angiology 54(3): 269-275

HIV-associated hematologic disorders are correlated with plasma viral load and improve under highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes 28(3): 221-225

HIV-associated immune dysfunction and delayed pubertal development in a cohort of young hemophiliacs. JAIDS Journal of Acquired Immune Deficiency Syndromes 21(4): 333-337, Aug 1

HIV-associated lipodystrophy syndrome. Pharmacotherapy 20(1): 13-22, Jan

HIV-associated lymphoma: report of three cases. East African Medical Journal 76(3): 176-177

HIV-associated malignomas. Onkologie 22(3): 240-244, July

HIV-associated multinucleated giant cells in lymphoid tissue of the Waldeyer's ring: a detailed study. Modern Pathology 13(12): 1293-1299

HIV-associated nephropathy. Kidney & Blood Pressure Research 22(4-6): 371-373

HIV-associated nephropathy in African Americans. Kidney International. Supplement: S43-S49

HIV-associated nephropathy in childhood. Archives de Pediatrie 5(12): 1353-1358, Dec

HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection. Kidney International 55(3): 1036-1040

HIV-associated nephropathy: Outcome and prognosis factors. Journal of the American Society of Nephrology 9(12): 2327-2335, Dec

HIV-associated nephropathy: Virologic issues related to renal sclerosis. Nephrology Dialysis Transplantation 18(Supplement 6): vi59-vi63, August

HIV-associated neurologic disease incidence changes:: Multicenter AIDS Cohort Study, 1990-1998. Neurology 56(2): 257-260

HIV-associated non-Hodgkin lymphoma: incidence, presentation, and prognosis. JAMA 285(14): 1880-1885

HIV-associated non-Hodgkin's lymphoma: highly active antiretroviral therapy improves remission rate of chemotherapy. Aids 13(6): 732-734

HIV-associated non-mycobacterial sepsis-bacteraemia, before and during the highly active antiretroviral therapy era. Aids 13(10): 1274-1276

HIV-associated parotid lymphoepithelial cysts. Journal of the American Dental Association 130(4): 528-532

HIV-associated pityriasis rubra pilaris responsive to triple antiretroviral therapy. British Journal of Dermatology 140(5): 931-934, May

HIV-associated primary CNS lymorbidity and utility of brain biopsy. Journal of the Neurological Sciences 163(1): 32-38, Feb 1

HIV-associated primary cervical non-Hodgkin's lymphoma and two other cases of primary pelvic non-Hodgkin's lymphoma. Gynecologic Oncology 90(1): 204-206, July

HIV-associated risk factors among young Canadian Aboriginal and non-Aboriginal men who have sex with men. International Journal of Std & Aids 10(9): 582-587

HIV-associated sensory neuropathies. Aids 16(16): 2105-2117

HIV-associated stroke. Stroke 32(2): 580-583

HIV-assoziierte zerebrale Toxoplasmose. Uebersicht und retrospektive Analyse von 36 Patienten. Nervenarzt 73(12): 1174-1178

HIV-derived protein gp120 suppresses P3 potential in rats: potential implications in HIV-associated dementia. Neuroreport 11(6): 1351-1355

HIV-gp160 modulates differentially the production in vitro of IgG, IgA and cytokines by blood and tonsil B lymphocytes from HIV-negative individuals. Clinical & Experimental Immunology 132(2): 304-308, May

HIV-induced T-cell syncytia release a two component T-helper cell chemoattractant composed of Nef and Tat. Journal of Cell Science 112: 3931-3941

HIV-infected adolescent and adult perceptions of tuberculosis testing, knowledge and medication adherence in the USA. Aids Care 12(1): 59-63

HIV-infected human Langerhans cells transmit infection to human lymphoid tissue ex vivo. Aids 14(6): 647-651

HIV-infected long-term nonprogressors: Epidemiology, mechanisms of delayed progression, clinical and research implications. Microbes & Infection 1(13): 1113-1120, Nov

HIV-infected parents and their children in the United States. American Journal of Public Health 90(7): 1074-1081

HIV-infected patient with a Rhodococcus equi pneumonia. Netherlands Journal of Medicine 57(1): 25-29, July

HIV-infected pregnant women and vertical transmission in Europe since 1986. AIDS (Hagerstown) 15(6): 761-770, 13 April

HIV-infected women delivering without antenatal care in a large Bangkok hospital, 1997. Southeast Asian Journal of Tropical Medicine and Public Health 31(1): 15-20

HIV-mediated gammadelta T cell depletion is specific for Vgamma2+ cells expressing the Jgamma1.2 segment. Aids Research and Human Retroviruses 19(1): 21-29

HIV-persistent infection and cytokine induction in mesangial cells: a potential mechanism for HIV-associated glomerulosclerosis. Aids 14(13): 2045-2047

HIV-positive gay and bisexual men: predictors of unsafe sex. Aids Care 15(1): 3-15

HIV-positive men differ in immunologic but not catecholamine response to an acute psychological stressor. Psychoneuroendocrinology 28(5): 643-656, July

HIV-positive men's sexual practices in the context of self-disclosure of HIV status. Journal of Acquired Immune Deficiency Syndromes 27(1): 79-85

HIV-related Hodgkin's disease with central nervous system involvement and association with Epstein-Barr virus. American Journal of Hematology 72(3): 216-219

HIV-related behaviors and perceptions among adults in 25 states: 1997 Behavioral Risk Factor Surveillance System. American Journal of Public Health 91(11): 1882-1888

HIV-related diarrhea is multifactorial and fat malabsorption is commonly present, independent of HAART. American Journal of Gastroenterology 96(6): 1831-1837, June

HIV-related lung cancer in the era of highly active antiretroviral therapy. Aids 17(3): 371-375

HIV-related lung cancer -- a growing concern?. International Journal of Std & Aids 14(10): 647-651

HIV-related malignancies: Community-based study using linkage of cancer registry and HIV registry data. International Journal of STD & AIDS 10(12): 795-802, Dec

HIV-related neuropathology, 1985 to 1999: rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes 31(2): 171-177

HIV-Related pulmonary hypertension: analytic review of 131 cases. Chest 118(4): 1133-1141

HIV-risk behavior among outpatients at a state psychiatric hospital: Prevalence and risk modeling. Behavior Therapy 30(3): 389-406, Fall

HIV-risk behaviors in adolescent substance abusers. Journal of Substance Abuse Treatment 16(2): 169-172, March

HIV-risk behaviours of American spring break vacationers: a case of situational disinhibition?. International Journal of Std & Aids 13(11): 733-743

HIV-seropositive individuals' optimistic beliefs about prognosis and relation to medication and safe sex adherence. Journal of General Internal Medicine 17(9): 677-683, September

HIV-Specific CD4(+) and CD8(+) immune responses are generated with a gp120-depleted, whole-killed HIV-1 immunogen with CpG immunostimulatory sequences of DNA. Journal of Interferon & Cytokine Research 20(12): 1131-1137

HIV-specific CD8 T-cell activity in uninfected injection drug users is associated with maintenance of seronegativity. Aids 16(12): 1595-1602

HIV-specific CD8+ T cell function in children with vertically acquired HIV-1 infection is critically influenced by age and the state of the CD4+ T cell compartment. Journal of Immunology 170(8): 4403-4410

HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. Journal of Experimental Medicine 192(1): 63-75

HIV-specific IgG in cervicovaginal secretions of exposed HIV-uninfected female sexual partners of HIV-infected men. Aids Research and Human Retroviruses 17(18): 1689-1693

HIV-specific cytotoxic T lymphocyte precursors exist in a CD28-CD8+ T cell subset and increase with loss of CD4 T cells. Aids 13(9): 1029-1033

HIV-specific cytotoxic T lymphocytes traffic to lymph nodes and localize at sites of HIV replication and cell death. Journal of Clinical Investigation 105(10): 1407-1417

HIV-specific cytotoxic T lymphocytes, HLA-A11, and chemokine-related factors may act synergistically to determine HIV resistance in CCR5 delta32-negative female sex workers in Chiang Rai, northern Thailand. Aids Research and Human Retroviruses 17(8): 719-734

HIV-specific effector cytotoxic T lymphocytes and HIV-producing cells colocalize in white pulps and germinal centers from infected patients. Blood 97(9): 2695-2701

HIV-specific immunity during structured antiviral drug treatment interruption. Vaccine 21(11-12): 1066-1071, 7 March

HIV-specific immunity following immunization with HIV synthetic envelope peptides in asymptomatic HIV-infected patients. Aids 13(15): 2003-2012

HIV/AIDS among African Americans: progress or progression?. Aids 14(9): 1237-1248

HIV/AIDS and blindness. Bulletin of the World Health Organization 79(3): 208-213

HIV/AIDS and care provider attributions: who's to blame?. Aids Care 14(4): 545-548

HIV/AIDS and drug abuse: epidemiology and prevention. Journal of Addictive Diseases 17(4): 91-103

HIV/AIDS epidemic in French Guiana: 1979-1997. JAIDS Journal of Acquired Immune Deficiency Syndromes 24(2): 178-181, June 1

HIV/AIDS in Bangladesh: a national surveillance. International Journal of Std & Aids 10(7): 471-474

HIV/AIDS in Bangladesh: an assessment of biomedical risk factors for transmission. International Journal of Std & Aids 10(5): 338-346

HIV/AIDS in children. Annals Academy of Medicine Singapore 32(2): 235-238, March

HIV/AIDS in nonurban Alabama: risk activities and access to services among HIV-infected persons. Southern Medical Journal 92(7): 677-683

HIV/AIDS interventions for midlife and older adults: current status and challenges. Journal of Acquired Immune Deficiency Syndromes 33 Suppl 2: S59-S67

HIV/AIDS knowledge, attitudes and beliefs based prediction models for practices in prison inmates, Sindh, Pakistan. Southeast Asian Journal of Tropical Medicine and Public Health 32(2): 351-361

HIV/AIDS patient involvement in antiretroviral treatment decisions. Aids Care 14(1): 17-26

HIV/AIDS prevention and care services and services for the aging: bridging the gap between service systems to assist older people. Journal of Acquired Immune Deficiency Syndromes 33 Suppl 2: S243-S250

HIV/AIDS prevention programs in developing countries are deficient without an appropriate scientific research infrastructure. Aids 17(7): 1114-1116

HIV/AIDS surveillance in Denmark: the challenges ahead. Journal of Acquired Immune Deficiency Syndromes 32 Suppl 1: S33-S38

HIV/AIDS surveillance in Germany. Journal of Acquired Immune Deficiency Syndromes 32 Suppl 1: S49-S54

HIV/AIDS surveillance in Japan, 1984-2000. Journal of Acquired Immune Deficiency Syndromes 32 Suppl 1: S55-S62

HIV/AIDS surveillance in the United States, 1981-2001. Journal of Acquired Immune Deficiency Syndromes 32 Suppl 1: S68-S85

HIV/AIDS surveillance systems in Australia. Journal of Acquired Immune Deficiency Syndromes 32 Suppl 1: S18-S23

HIV/AIDS treatment and HIV vaccines for Africa. Lancet 359(9325): 2261-2267

HIV/AIDS, drug addiction and their effect on motherhood. Rossiiskii Vestnik Perinatologii i Pediatrii 45(5): 38-44

HIV/AIDS: Destabilising national security and the multi-national response. Revue Internationale des Services de Sante des Forces Armees 74(1): 3-12, Mars

HIV/Aids: Avaliacao democratica e a construcao coletiva do conhecimento. Revista de Saude Publica 36(4 Suplemento): 2-3

HIV/HTLV co-infection: frequency and epidemiological characteristics among patients admitted to an Italian hospital. Infection 31(3): 172-173

HIV/STD-protective benefits of living with mothers in perceived supportive families: a study of high-risk African American female teens. Preventive Medicine 33(3): 175-178

HIV/STD: the women to blame? Knowledge and attitudes among STD clinic attendees in the second decade of HIV/AIDS. International Journal of Std & Aids 10(8): 543-547

HIV/Hepatitis B and C co-infection: pathogenic interactions, natural history and therapy. Antiviral Chemistry & ChemoTherapy 12 Suppl 1: 73-91

HIV/sexually transmitted disease education and prevention in US bathhouse and sex club environments. Aids 14(5): 625-626

HIV1 infection in extra-European students in Turin (Italy): Epidemiologic pattern and risk factors. European Journal of Epidemiology 16(2): 119-121

HIV: A new role for Nef in the spread of HIV. Current Biology 9(12): R459-R461, June 17

HIV: Clinical manifestations. Journal of Allergy & Clinical Immunology 110(1): 3-16, July

HIV: Mother to child transmission, current knowledge and on-going studies. International Journal of Gynecology & Obstetrics 63(SUPPL 1): S161-S165, Dec

HIV: much at stake with kidneys?. Journal of the American Society of Nephrology 11(11): 2138-2140

HIV: reactive oxygen species, enveloped viruses and hyperbaric oxygen. Medical Hypotheses 55(3): 232-238

HIV: The deadly passenger in dendritic cells. Current Biology 9(7): R248-R250, April 8

HL-1 myocytes exhibit PKC and KATP channel-dependent delta opioid preconditioning. Journal of Surgical Research 114(2): 187-194, October

HL-60 cell growth-conditioned medium is an effective inducer of myeloperoxidase expression in K-562 human leukemia cells. Leukemia Research 26(11): 1017-1025, November

HL-60 cells degrade alpha-actinin to produce a fragment that promotes monocyte/macrophage maturation. Experimental Hematology 27(2): 345-352

HL-60 differentiating activity and flavonoid content of the readily extractable fraction prepared from citrus juices. Journal of Agricultural and Food Chemistry 47(1): 128-135

HLA A*02 allele and B-associated haplotype diversity in Indians. British Journal of Biomedical Science 60(2): 109-112

HLA A*02 allele frequencies and B haplotype associations in Western Indians. Human Immunology 64(5): 562-566, May

HLA A2 allele is associated with age at onset of Alzheimer's disease. Annals of Neurology 45(3): 397-400, March

HLA B27 in health and disease: a double-edged sword?. Rheumatology 41(8): 857-868

HLA B27 polymorphism in Western India. Tissue Antigens 60(1): 98-101, July

HLA Class I expression on human cancer cells: Implications for effective immunotherapy. Human Immunology 61(2): 158-165, Feb

HLA Class II peptide-binding and autoimmunity. Tissue Antigens 59(2): 78-87, February

HLA DMA and DMB show no association with rheumatoid arthritis in US Caucasians. European Journal of Immunogenetics 28(5): 539-543, October

HLA DPB1*0201 gene confers disease susceptibility in Japanese with childhood onset type I diabetes, independent of HLA-DR and DQ genotypes. Diabetes Research & Clinical Practice 47(1): 49-55, Jan

HLA DQ alleles and interleukin-10 polymorphism associated with Chlamydia trachomatis-related tubal factor infertility: a case-control study. Human Reproduction 17(8): 2073-2078

HLA DQA1*0501 and DRB1*0301 antigens do not independently convey susceptibility to Graves' disease. Journal of Endocrinological Investigation 24(2): 88-91

HLA DQalpha and HLA DRB genotyping of bloodstain by direct-PCR method. Research & Practice in Forensic Medicine (42): 37-40

HLA DR-DQ-encoded genetic determinants of childhood-onset type 1 diabetes in Finland: An analysis of 622 nuclear families. Tissue Antigens 62(2): 162-169, August

HLA DRB genotyping with SSO probes and its application to paternity testing. Research & Practice in Forensic Medicine 41(0): 47-51

HLA DRB1 and DQB1 gene diversity in Maratha community from Mumbai India. International Journal of Human Genetics 3(1): 39-43, March

HLA DRB1*0405-DQB1*0401 haplotype is associated with autoimmune pancreatitis in the Japanese population. Gastroenterology 122(5): 1264-1269, May

HLA DRB1*1501 and intrathecal inflammation in multiple sclerosis. Tissue Antigens 55(4): 312-318, April

HLA DRB1, DMA, and DMB gene polymorphisms in rheumatoid arthritis. Human Immunology 60(3): 245-249, March

HLA DRB1, DQA1, DQB1 and DPB1 polymorphisms in Namibian Khoi and San and in the Xhosa and South African mixed-ancestry populations. South African Journal of Science 99(1-2): 81-89, January-February

HLA alleles and IDDM in children in Hungary: A comparison with Finland. Human Immunology 62(4): 391-398, April

HLA alleles and haplotypes in the Turkish population: Relatedness to Kurds, Armenians and other Mediterraneans. Tissue Antigens 57(4): 308-317, April

HLA alleles and susceptibility to dermatological disorders associated with Helicobacter pylori infection: a significant association to HLA-Cw*06. Folia Biologica 47(2): 62-65

HLA alleles in isolated populations from north Spain: Origin of the Basques and the ancient Iberians. Tissue Antigens 61(5): 384-392, May

HLA alloimmunization in patients receiving multitransfusions of red blood cells. Southeast Asian Journal of Tropical Medicine and Public Health 32(2): 419-424

HLA alloimmunization in patients requiring ventricular assist device support. Journal of Heart & Lung Transplantation 21(11): 1218-1224, November

HLA and AIDS: A cautionary tale. Trends in Molecular Medicine 7(9): 379-381, September

HLA and RBC immunization after filtered and buffy coat-depleted blood transfusion in cardiac surgery: A randomized controlled trial. Transfusion (Bethesda) 43(6): 765-771, June

HLA and beta-myosin heavy chain do not influence susceptibility to Chagas disease cardiomyopathy. Microbes and Infection 2(7): 745-751

HLA and cytokine gene polymorphisms in biliary atresia. Liver 22(3): 213-219, June

HLA and cytokine gene polymorphisms in relation to occurrence of palindromic rheumatism and its progression to rheumatoid arthritis. Journal of Rheumatology 29(11): 2319-2326

HLA and hypocretin studies in Korean patients with narcolepsy. Sleep 25(4): 440-444

HLA and in vitro susceptibility to HIV infection. Molecular Immunology 38(12-13): 959-967, May

HLA and interleukin 1 gene polymorphisms in primary biliary cirrhosis: associations with disease progression and disease susceptibility. Gut 48(3): 397-402

HLA and other host factors in transfusion-acquired HIV-1 infection. Human Immunology 61(2): 172-176, Feb

HLA and schizophrenia: refutation of reported associations with A9 (A23/A24), DR4, and DQbeta1*0602. American Journal of Medical Genetics 88(4): 416-421

HLA and self-limiting, unclassified rheumatism. A role for HLA-B35?. Journal of Rheumatology 26(11): 2400-2403

HLA and susceptibility to cervical neoplasia. Human Immunology 60(4): 337-342, April

HLA antibodies present in the sera of sensitized patients awaiting renal transplant are also reactive to swine leukocyte antigens. Transplantation 66(8): 1074-1080

HLA antigen and gene frequencies in Eskimos of East Greenland. European Journal of Immunogenetics 27(2): 93-97, April

HLA antigen distribution in Marathi speaking Hindu population from Mumbai, Maharastra, India. Journal of Human Ecology 10(5-6): 367-372, Sept -Nov

HLA antigen distribution in selected Gujarati subcaste from Mumbai, Maharastra, India. International Journal of Human Genetics 3(3): 135-138, September

HLA antigen distribution in selected caste groups from Mumbai, Maharastra, India. Journal of Human Ecology 13(3): 209-215, May

HLA antigen frequencies in end-stage idiopathic and ischaemic cardiomyopathy. International Journal of Cardiology 68(1): 31-37, Jan

HLA antigens and primary osteoarthritis of the hand. Journal of Rheumatology 30(6): 1298-1304

HLA antigens associated with susceptibility/resistance to HIV-1 infection. Human Immunology 59(12): 802-815, Dec

HLA antigens in Malay patients with systemic lupus erythematosus: association with clinical and autoantibody expression. Korean Journal of Internal Medicine 16(2): 123-131

HLA antigens in alkaptonuric patients. Panminerva Medica 43(3): 145-148

HLA antigens in lyophilised corneal lenticules. Acta Ophthalmologica Scandinavica 76(6): 653-657, Dec

HLA antigens in nocturnal enuresis. International Urology & Nephrology 31(6): 811-815

HLA antigens in patients with interferon-alpha-induced autoimmune thyroid disorders in chronic hepatitis C. Journal of Hepatology 30(5): 794-800

HLA antigens in patients with laryngeal carcinoma. Revue Internationale des Services de Sante des Forces Armees 74(3): 156-157, September

HLA antigens in patients with latent syphilis. Vestnik Dermatologii i Venerologii (5): 23-26

HLA antigens in patients with variant angina in Japan. International Journal of Cardiology 70(3): 249-252, Aug 31

HLA antigens may influence the age of onset of psoriasis and psoriatic arthritis. Journal of Rheumatology 30(3): 505-507

HLA antigens, alleles and haplotypes among the Yup'ik Alaska natives: Report of the ASHI minority workshops, part II. Human Immunology 63(7): 614-625, July

HLA association of amoxicillin-clavulanate-induced hepatitis. Gastroenterology 117(5): 1181-1186, Nov

HLA association with autoimmune disease: a failure to protect?. Rheumatology 39(10): 1060-1066

HLA association with hepatitis C virus infection. Human Immunology 61(3): 348-353, March

HLA associations in type 1 diabetes: Merging genetics and immunology. Trends in Immunology 22(9): 467-469, September

HLA associations of anti-beta2 glycoprotein I response in a Greek cohort with antiphospholipid syndrome and meta-analysis of four ethnic groups. Human Immunology 60(12): 1274-1280, Dec

HLA associations of seropositive rheumatoid arthritis in a Cree and Ojibway population. Journal of Rheumatology 25(12): 2319-2323

HLA associations with HBV carriage and proteinuria. Pediatric Nephrology 17(9): 724-729

HLA associations with occupational sensitization to rat lipocalin allergens: a model for other animal allergies?. Journal of Allergy and Clinical Immunology 111(4): 795-799

HLA binding and T cell recognition of a tissue transglutaminase-modified gliadin epitope. European Journal of Immunology 29(8): 2506-2514, Aug

HLA class I allele distributions in six Pacific/Asian populations: Evidence of selection at the HLA-A locus. Tissue Antigens 53(4 PART 1): 311-319, April

HLA class I alleles and susceptibility to psoriasis vulgaris. Central-European Journal of Immunology 25(4): 198-201

HLA class I alleles associated with susceptibility or resistance to human immunodeficiency virus type 1 infection among a population in Chaco Province, Argentina. Journal of Infectious Diseases 182(5): 1523-1526

HLA class I and II alleles and susceptibility to generalized pustular psoriasis: significant associations with HLA-Cw1 and HLA-DQB1*0303. Journal of Dermatology 25(9): 573-581

HLA class I and II in Lambert-Eaton myasthenic syndrome without associated tumor. Human Immunology 62(8): 809-813, August

HLA class I and II in black children with hepatitis B virus-associated membranous nephropathy. Kidney International 61(4): 1510-1515

HLA class I and class II allele and haplotype diversity in Martinicans. Tissue Antigens 57(3): 200-207, March

HLA class I and class II allele distribution in the Peruvian population. Tissue Antigens 56(6): 507-514, December

HLA class I and class II profiles of patients presenting with Sydenham's chorea. Journal of Neurology 247(2): 122-128, Feb

HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story. Molecular Medicine Today 5(4): 178-186, April

HLA class I antigen loss, tumor immune escape and immune selection. Vaccine 20(Supplement 4): A40-A45, 19 December

HLA class I deficiencies due to mutations in subunit 1 of the peptide transporter TAP1. Journal of Clinical Investigation 103(5): R9-R13

HLA class I distribution in Japanese patients with schizophrenia. American Journal of Medical Genetics 114(1): 42-45, January 8

HLA class I diversity in Kolla Amerindians. Human Immunology 62(2): 170-179, February

HLA class I expression and chromosomal deletions at 6p and 15q in head and neck squamous cell carcinomas. Tissue Antigens 54(3): 235-245, Sept

HLA class I expression in bladder carcinomas. Tissue Antigens 62(4): 324-327, October

HLA class I homozygosity accelerates disease progression in human immunodeficiency virus type 1 infection. Aids Research and Human Retroviruses 15(4): 317-324

HLA class I in three West African ethnic groups: genetic distances from sub-Saharan and Caucasoid populations. Tissue Antigens 57(2): 128-137

HLA class I molecule expression is up-regulated during maturation of dendritic cells, protecting them from natural killer cell-mediated lysis. Immunology Letters 76(1): 37-41, February 1

HLA class I molecules expression: evaluation of different immunocytochemical methods in malignant lesions. Anticancer Research 21(4a): 2435-2440

HLA class I polymorphism has a dual impact on ligand binding and chaperone interaction. Human Immunology 63(4): 248-255, April

HLA class I polymorphism, as characterised by PCR-SSOP, in a Brazilian exogamic population. Tissue Antigens 56(5): 417-427, November

HLA class I typing of volunteers for a bone marrow registry: QC analysis by DNA-based methodology identifies serological typing discrepancies in the assignment of HLA-A and B antigens. Tissue Antigens 59(3): 211-215, March

HLA class I-restricted cytotoxic T-cell epitopes of the respiratory syncytial virus fusion protein. Journal of Virology 74(21): 10240-4

HLA class I-restricted recognition of an HIV-derived epitope peptide by a human T cell receptor alpha chain having a Vdelta1 variable segment. European Journal of Immunology 33(10): 2910-2916

HLA class II DR-DQ and increased risk of cervical cancer among Senegalese women. Cancer Epidemiology, Biomarkers & Prevention 10(10): 1037-1045

HLA class II DRB1 and DQB1 allelic polymorphism and sclerosing lymphocytic lobulitis of the breast. Journal of Clinical Pathology 52(6): 445-449

HLA class II DRB1, DQB1, DPB1 polymorphism and cardiomyopathy due to Trypanosoma cruzi chronic infection. Human Immunology 61(3): 320-325, March

HLA class II allele and haplotype frequencies in Koreans based on 107 families. Tissue Antigens 59(6): 475-486, June

HLA class II allele distribution in the Gypsy community of Andalusia, southern Spain. Tissue Antigens 57(2): 138-143, February

HLA class II alleles and haplotypes in Icelandic Type I diabetic patients: comparison of Icelandic and Norwegian populations. Diabetologia 45(3): 452-453

HLA class II alleles and synovial fluid cytology in RA. Annals of the Rheumatic Diseases 60(5): 542-544

HLA class II alleles associations of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Lupus 9(1): 47-55

HLA class II alleles in Chinese patients with hepatocellular carcinoma. Liver 21(2): 143-148, Apr

HLA class II alleles in Japanese patients with immune thrombocytopenic purpura. Associations with anti-platelet glycoprotein autoantibodies and responses to splenectomy. Tissue Antigens 56(4): 337-343, October

HLA class II alleles in Japanese patients with inflammatory bowel disease. Tissue Antigens 53(4 PART 1): 350-358, April

HLA class II and TNF genes in African Americans from the southeastern United States: Regional differences in allele frequencies. Human Immunology 64(6): 639-647, June

HLA class II antibodies in transfusion-related acute lung injury. Transfusion (Bethesda) 41(10): 1244-1248, October

HLA class II antigen expression in uveal melanoma: Correlation with clinicopathological features. Experimental Eye Research 77(2): 175-180, August

HLA class II antigens associated with lupus nephritis in Italian SLE patients. Human Immunology 64(4): 462-468

HLA class II antigens in South African Blacks with type I diabetes. Tissue Antigens 57(4): 348-352, April

HLA class II association with Type I allergy to house dust mite and Japanese cedar pollen in Japanese subjects. Allergology International 47(4): 285-291, Dec

HLA class II association with rheumatoid arthritis: Facts and interpretations. Human Immunology 61(12): 1254-1261, December

HLA class II associations with Type 1 diabetes mellitus: A multivariate approach. Tissue Antigens 57(2): 144-150, February

HLA class II associations with rheumatic heart disease are more evident and consistent among clinically homogeneous patients. Circulation 99(21): 2784-2790

HLA class II favors clearance of HCV infection and progression of the chronic liver damage. Journal of Hepatology 30(6): 984-989, June

HLA class II gene polymorphisms in antiphospholipid syndrome: haplotype analysis in 83 Caucasoid patients. Rheumatology 40(1): 31-36

HLA class II genes determine the natural variance of hepatitis C viral load. Hepatology 33(1): 224-230

HLA class II genotypes associated with chronic hepatitis C virus infection and response to alpha-interferon treatment in Poland. Liver 20(3): 234-239

HLA class II haplotype and quantitation of WT1 RNA in Japanese patients with paroxysmal nocturnal hemoglobinuria. Blood 100(1): 22-28

HLA class II haplotype associations with inflammatory bowel disease in Jewish (Ashkenazi) and non-Jewish Caucasian populations. Human Immunology 61(3): 326-333

HLA class II haplotypes associated with pulmonary interstitial lesions of polymyositis/dermatomyositis in Japanese patients. Tissue Antigens 59(1): 25-30, January

HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. Tissue Antigens 53(5): 459-469, May

HLA class II homozygosity confers susceptibility to common variable immunodeficiency (CVID). Clinical and Experimental Immunology 116(3): 516-520

HLA class II immunogenetics and incidence of insulin-dependent diabetes mellitus in the population of Cantabria (Northern Spain). Human Immunology 60(10): 990-1000

HLA class II is associated with distal interphalangeal osteoarthritis. Annals of the Rheumatic Diseases 62(3): 227-230

HLA class II markers and clinical heterogeneity in Swedish patients with primary biliary cirrhosis. Tissue Antigens 59(5): 381-387, May

HLA class II molecular polymorphisms in healthy Slavic individuals from North-Western Russia. Tissue Antigens 54(5): 517-520, Nov

HLA class II polymorphism contributes to specify desmoglein derived peptides in pemphigus vulgaris and pemphigus foliaceus. Journal of Autoimmunity 15(1): 67-73

HLA class II polymorphism in Aka Pygmies and Bantu Congolese and a reassessment of HLA-DRB1 African diversity. Tissue Antigens 58(4): 211-222

HLA class II polymorphism in Thai patients with non-Hodgkin's lymphoma. European Journal of Immunogenetics 26(6): 389-392, Dec

HLA class II polymorphism in a Gabonese Banzabi population. Tissue Antigens 53(6): 580-585, June

HLA class II polymorphism in cystic fibrosis. A possible modifier of pulmonary phenotype. American Journal of Respiratory and Critical Care Medicine 159(5 Pt 1): 1464-1468

HLA class II polymorphisms and susceptibility to recurrent respiratory papillomatosis. Journal of Virology 77(3): 1927-1939

HLA class II sequence-based typing in normal Saudi individuals. Tissue Antigens 60(3): 259-261, September

HLA class II signals sensitize B lymphocytes to apoptosis via Fas/CD95 by increasing FADD recruitment to activated Fas and activation of caspases. Human Immunology 63(5): 375-383, May

HLA class II transgenic mice authenticate restriction of myelin oligodendrocyte glycoprotein-specific immune response implicated in multiple sclerosis pathogenesis. International Immunology 15(4): 535-546

HLA class II typing of whole genome amplified mouth swab DNA. Tissue Antigens 56(6): 530-538, December

HLA class II variation in indigenous populations from Thailand. Hereditas (Lund) 132(2): 129-136, April

HLA class II-restricted CD4+ T cell responses directed against influenza viral antigens postinfluenza vaccination. Journal of Immunology 171(6): 3163-3169

HLA class-I-restricted and colon-specific cytotoxic T cells from lamina propria lymphocytes of patients with ulcerative colitis. Journal of Clinical Immunology 21(6): 381-389, November

HLA compatibility and antigenic re-exposure: Influence on the outcome of second cadaveric renal transplants. Archivos Espanoles de Urologia 53(1): 53-64, Jan -Feb

HLA compatibility in organ transplantation. Nephrology, Dialysis, Transplantation 16 Suppl 6: 147-149

HLA compatibility requirements for CD8(+)-T-cell-mediated suppression of human immunodeficiency virus replication. Journal of Virology 72(12): 10165-10170

HLA complex genes in type 1 diabetes and other autoimmune diseases. Which genes are involved?. Trends in Genetics 17(2): 93-100, February

HLA diversity, differentiation, and haplotype evolution in Mesoamerican natives. Human Immunology 62(4): 378-390, April

HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Experimental Hematology 31(10): 890-896

HLA expression in cancer: Implications for T cell-based immunotherapy. Immunogenetics 53(4): 255-263, May-June

HLA expression in uveal melanoma: There is no rule without some exception. Human Immunology 63(6): 444-451, June

HLA genes associated with autoimmunity and progression to disease in type 1 diabetes. Tissue Antigens 61(2): 146-153, February

HLA genes in Arabic-speaking Moroccans: Close relatedness to Berbers and Iberians. Tissue Antigens 55(3): 239-249, March

HLA genes in Macedonians and the sub-Saharan origin of the Greeks. Tissue Antigens 57(2): 118-127, February

HLA genes in Mexican Mazatecans, the peopling of the Americas and the uniqueness of Amerindians. Tissue Antigens 56(5): 405-416, November

HLA genetics for diagnosis of susceptibility to early-onset periodontitis. Journal of Periodontal Research 34(7): 374-378, Oct

HLA genotypes and disease severity assessed by magnetic resonance imaging findings in patients with multiple sclerosis. Journal of Neurology 250(9): 1099-1106

HLA genotyping of 5,000- and 6,000-year-old ancient bones in Japan. Tissue Antigens 54(1): 53-58, July

HLA haplotype analysis in Finnish patients with rheumatoid arthritis. Arthritis and Rheumatism 44(2): 315-322

HLA haplotype is associated with diabetes among atomic bomb survivors. Human Immunology 64(9): 910-916, September

HLA haplotypes and microsatellite polymorphisms in and around the major histocompatibility complex region in a Native American population with a high prevalence of scleroderma (systemic sclerosis). Tissue Antigens 53(1): 74-80

HLA haplotypes and susceptibility to rheumatoid arthritis. Scandinavian Journal of Rheumatology 31(5): 275-278

HLA in Egyptian children with biliary atresia. Journal of Pediatrics 141(3): 432-433

HLA in breast cancer: Its relevance for immunotherapy. Breast 7(6): 308-313, Dec

HLA in coeliac disease families: A novel test of risk modification by the 'other' haplotype when at least one DQA1*05-DQB1*02 haplotype is carried. Tissue Antigens 60(2): 147-154, August

HLA in coeliac disease: Unravelling the complex genetics of a complex disorder. Tissue Antigens 61(2): 105-117, February

HLA in the Azores Archipelago: Possible presence of Mongoloid genes. Tissue Antigens 54(4): 349-359, Oct

HLA is a candidate region for psoriatic arthritis: Evidence for excessive HLA sharing in sibling pairs. Human Immunology 64(9): 887-889, September

HLA markers associated with progression to AIDS are also associated with susceptibility to cytomegalovirus retinitis. Aids 17(14): 2133-2136

HLA matching and the United Network for Organ Sharing Allocation System: impact of HLA matching on African-American recipients of cadaveric kidney transplants. Transplantation 74(11): 1634-1636

HLA matching in Asian recipients of kidney grafts from unrelated living or cadaveric donors. Human Immunology 61(2): 115-119, Feb

HLA matching in hematopoietic cell transplantation. Human Immunology 61(2): 92-100, Feb

HLA microsatellite associations with insulin-dependent diabetes mellitus in Singaporean Chinese. Human Immunology 60(9): 894-900, Sept

HLA molecular markers in Tuvinians: A population with both Oriental and Caucasoid characteristics. Annals of Human Genetics 65(3): 245-261, May

HLA patterns in patients with nasal polyposis. European Archives of Oto-Rhino-Laryngology 257(3): 137-139, March

HLA phenotype and cytokine-induced tumor control in advanced renal cell cancer. Cancer BioTherapy & Radiopharmaceuticals 16(5): 401-409

HLA polymorphism in Bulgarians defined by high-resolution typing methods in comparison with other populations. Tissue Antigens 60(6): 496-504, December

HLA polymorphism in a Majorcan population of Jewish descent: Comparison with Majorca, Minorca, Ibiza (Balearic Islands) and other Jewish communities. Tissue Antigens 60(4): 282-291

HLA polymorphism in six ethnic groups from Pakistan. Tissue Antigens 59(6): 492-501, June

HLA polymorphism in the Murcia population (Spain): In the cradle of the archaeologic Iberians. Human Immunology 62(9): 910-921

HLA polymorphism in type 1 diabetes Tunisians. Annales de Genetique 45(1): 45-50, January-March

HLA profile of three ethnic groups living in the North-Western region of Russia. Tissue Antigens 59(1): 38-43, January

HLA relationships of pregnancy, microchimerism and autoimmune disease. Journal of Reproductive Immunology 52(1-2): 77-84, October-November

HLA system affects the age-at-onset in chronic myeloid leukemia. American Journal of Hematology 73(4): 256-262

HLA tetramer-based artificial antigen-presenting cells for stimulation of CD4+ T cells. Clinical Immunology (Orlando) 106(1): 16-22, January

HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: Results from the European genetics cluster on celiac disease. Human Immunology 64(4): 469-477

HLA typing and Parkinson's disease. European Neurology 50(2): 64-68

HLA typing in a Kenyan cohort identifies novel class I alleles that restrict cytotoxic T-cell responses to local HIV-1 clades. Aids 16(14): 1899-1904

HLA typing in twins with vesicoureteral reflux. Hinyokika Kiyo. Acta Urologica Japonica 49(2): 95-98

HLA typing strategies in a cord blood bank. Haematologica 87(8): 851-854

HLA, aging, and longevity: A critical reappraisal. Human Immunology 61(9): 942-949, September

HLA-A alleles of patients with pyothorax-associated lymphoma: Anti-Epstein-Barr virus (EBV) host immune responses during the development of EBV latent antigen-positive lymphomas. International Journal of Cancer 82(5): 630-634

HLA-A and HLA-B in Kenya, Africa: Allele frequencies and identification of HLA-B*1567 and HLA-B*4426. Tissue Antigens 59(5): 370-380, May

HLA-A and HLA-B transcription decrease with ageing in peripheral blood leucocytes. Clinical & Experimental Immunology 125(2): 245-250, August

HLA-A typing by reference strand-mediated conformation analysis (RSCA) using a capillary-based semi-automated genetic analyser. Tissue Antigens 54(4): 400-404

HLA-A*02 allele frequencies and haplotypic associations in Koreans. Tissue Antigens 55(3): 250-256, March

HLA-A*0201 restricted CD8+ T-lymphocyte responses to malaria: identification of new Plasmodium falciparum epitopes by IFN-gamma ELISPOT. Parasite Immunology 22(10): 501-514

HLA-A*1101-restricted cytotoxic T lymphocyte recognition for a novel epitope derived from the HIV-1 Env protein. AIDS (Hagerstown) 13(18): 2597-2599

HLA-A*1101-restricted cytotoxic T lymphocyte recognition of HIV-1 Pol protein. Aids 13(11): 1413-1414

HLA-A*2416: A new allele of the HLA-A19 lineage. Tissue Antigens 55(2): 178-181, Feb

HLA-A*26, HLA-B*4002, HLA-B*4006, and HLA-B*4801 alleles predispose to adult T cell leukemia: the limited recognition of HTLV type 1 tax peptide anchor motifs and epitopes to generate anti-HTLV type 1 tax CD8(+) cytotoxic T lymphocytes. Aids Research and Human Retroviruses 17(11): 1047-1061

HLA-A*28 allele frequencies in the five major U.S. ethnic groups. Human Immunology 60(2): 159-167, Feb

HLA-A*30 alleles and associated haplotypes in the Korean population. Tissue Antigens 54(2): 198-200, Aug

HLA-A*3306, a novel variant in the Indian population. Tissue Antigens 59(5): 421-423, May

HLA-A*6817, identified in the Kolla Amerindians of North-West Argentina possesses a novel nucleotide substitution. Tissue Antigens 55(5): 453-454, May

HLA-A*9, a probable secondary susceptibility marker to ankylosing spondylitis in Basque patients. Tissue Antigens 53(2): 161-166, Feb

HLA-A, -B, -C genotyping and expression in human nonlymphoid tumor cell lines. Journal of ImmunoTherapy 22(1): 7-15

HLA-A, -B, -C polymorphism in a UK Ashkenazi Jewish potential bone marrow donor population. Tissue Antigens 53(1): 41-50, Jan

HLA-A, -B, -C, -DRB1, DRB3, DRB4, DRB5 and DQB1 polymorphism detected by PCR-SSP in a semi-urban HIV-positive Ugandan population. Experimental and Clinical Immunogenetics 16(1): 17-25

HLA-A, -B, -DRB1 allele and haplotype frequencies in 510 Koreans. Tissue Antigens 53(4 PART 1): 386-390, April

HLA-A, B, Cw and DRB1, DRB3/4/5, DQB1, DPB1 frequencies in German immunoglobulin A-deficient individuals. Scandinavian Journal of Immunology 52(2): 207-211, August

HLA-A, HLA-B and HLA-C polymorphism in the Slovak population. Folia Biologica 46(4): 153-156

HLA-A11-restricted epitope polymorphism among Epstein-Barr virus strains in the highly HLA-A11-positive Chinese population: incidence and immunogenicity of variant epitope sequences. Journal of Virology 77(21): 11507-11516

HLA-A2 homozygosity but not heterozygosity is associated with Alzheimer disease. Neurology 58(6): 973-975

HLA-A2 restricted, melanocyte-specific CD8(+) T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA/MART1. Journal of Investigative Dermatology 116(6): 891-897

HLA-A2 subtype distribution among Beijing Chinese and its effect on CTL response in vitro to p53 protein based synthetic peptides loaded on dendritic cells. Zhonghua Weishengwuxue He Mianyixue Zazhi 19(1): 47-50, Jan

HLA-A2.1 restricted peptides from the HBx antigen induce specific CTL responses in vitro and in vivo. Vaccine 20(31-32): 3770-3777, 1 November

HLA-A2.1/K(b) transgenic murine dendritic cells transduced with an adenovirus encoding human gp100 process the same A2.1-restricted peptide epitopes as human antigen-presenting cells and elicit A2.1-restricted peptide-specific CTL. Cellular Immunology 204(1): 29-37

HLA-A3 increases and HLA-DR1 decreases the risk of acute graft-versus-host disease after HLA-matched sibling bone marrow transplantation for chronic myelogenous leukaemia. British Journal of Haematology 114(1): 36-41, July

HLA-A3 restricted mutant ras specific cytotoxic T-lymphocytes induced by vaccination with T-helper epitopes. Journal of Molecular Medicine 81(1): 43-50

HLA-A3 supermotif defined by quantitative structure-activity relationship analysis. Protein Engineering 16(1): 11-18

HLA-A33 and -B44 and susceptibility to postherpetic neuralgia (PHN). Tissue Antigens 53(3): 263-268

HLA-A33/B44/DR6 is highly related to intrahepatic cholestasis induced by tiopronin. Digestive Diseases and Sciences 45(6): 1103-1108

HLA-AB typing by polymerase-chain reaction with sequence-specific primers: More accurate, less errors, and increased resolution compared to serological typing. Tissue Antigens 58(5): 299-307, November

HLA-B locus sequence-based typing. Tissue Antigens 53(3): 275-281, March

HLA-B locus-specific downregulation in human melanoma requires enhancer A as well as a sequence element located downstream of the transcription initiation site. Immunogenetics 52(1-2): 121-128, November

HLA-B polymorphism affects interactions with multiple endoplasmic reticulum proteins. European Journal of Immunology 30(10): 3021-3028, October

HLA-B typing by reference strand mediated conformation analysis using a capillary-based semiautomated genetic analyzer. Human Immunology 62(4): 414-418, April

HLA-B*0702 transgenic, H-2KbDb double-knockout mice: phenotypical and functional characterization in response to influenza virus. International Immunology 15(6): 765-772

HLA-B*0811: Another example of a single point substitution of the HLA-B*0801 allele. Tissue Antigens 56(5): 457-459, November

HLA-B*15 diversity in the Korean population. Tissue Antigens 56(5): 428-435, November

HLA-B*15 subtypes in the population of north-eastern Thailand. European Journal of Immunogenetics 30(2): 153-158, April

HLA-B*1559: A hybrid allele including exon 2 of HLA-B35 and exon 3 of HLA-B15 and serologically typed as B35. Tissue Antigens 56(5): 460-462, November

HLA-B*27 subtyping by PCR-RFLP in Spanish patients with ankylosing spondylitis. Tissue Antigens 52(5): 492-496

HLA-B*35-restricted CD8 T cell epitopes in the antigen 85 complex of Mycobacterium tuberculosis. Journal of Infectious Diseases 183(6): 928-934

HLA-B*35-restricted CD8(+)-T-cell epitope in Mycobacterium tuberculosis Rv2903c. Infection and Immunity 70(2): 981-984

HLA-B*3531, a hybrid of B35 and B61, implications for diagnostic approaches to alleles with complex ancestral compositions. Tissue Antigens 60(1): 95-97

HLA-B*39 allele confers susceptibility to osteoarticular complications in human brucellosis. Journal of Rheumatology 30(5): 1051-1053

HLA-B*4012: A new allele with unique serological features. Tissue Antigens 56(2): 180-183, August

HLA-B*4034 identified in a UK Caucasoid potential bone marrow donor. Immunogenetics 53(1): 43-44

HLA-B*4413 identified in a UK Caucasoid potential bone marrow donor. Tissue Antigens 55(2): 185-187, Feb

HLA-B*4431: A new HLA-B variant with a complex ancestral history involving HLA-B*44, B*40 and B*07 alleles. Tissue Antigens 60(1): 91-94, July

HLA-B*4703: Sequence confirmation, serology and distribution. Tissue Antigens 53(6): 586-590, June

HLA-B*5130, a new HLA-B allele carrying a rare nucleotide substitution in exon 4. Tissue Antigens 61(1): 97-98, January

HLA-B*5703 independently associated with slower HIV-1 disease progression in Rwandan women. Aids 13(14): 1990-1991

HLA-B*8202 identified in a caucasoid potential bone marrow donor. Tissue Antigens 56(2): 188-191, August

HLA-B22 diversity including a novel B54 variant (B*5507) in the Korean population. Human Immunology 60(8): 731-737

HLA-B27 alone rather than B27-related class I haplotypes contributes to ankylosing spondylitis susceptibility. Human Immunology 61(2): 131-139, Feb

HLA-B27 and its subtypes in 4 Taiwanese Aborigine tribes: a comparison to Han Chinese patients with ankylosing spondylitis. Journal of Rheumatology 30(2): 321-325

HLA-B27 and the pathogenesis of spondyloarthritis. Tissue Antigens 60(3): 191-205, September

HLA-B27 and the seronegative spondyloarthropathies. American Journal of the Medical Sciences 316(4): 239-249

HLA-B27 associated spondyloarthropathy and severe ascending aortitis. Journal of Rheumatology 27(8): 2038-2040

HLA-B27 associated spondyloarthropathy, an autoimmune disease based on crossreactivity between bacteria and HLA-B27?. Annals of the Rheumatic Diseases 58(10): 598-610

HLA-B27 expression and reactive arthritis susceptibility in two patient cohorts infected with Salmonella Typhimurium. Australian & New Zealand Journal of Medicine 30(1): 28-32, Feb

HLA-B27 expression by flow cytometry: An analysis of 7 years quality assurance data. Journal of Immunological Methods 243(1-2): 51-57, 21 September

HLA-B27 expression does not modulate intracellular Chlamydia trachomatis infection of cell lines. Infection and Immunity 69(11): 6670-6675

HLA-B27 has no effect on the phenotypic expression of progressive ankylosis in ank/ank mice. Journal of Rheumatology 27(5): 1257-1259

HLA-B27 misfolding is associated with aberrant intermolecular disulfide bond formation (dimerization) in the endoplasmic reticulum. Journal of Biological Chemistry 277(26): 23459-23468

HLA-B27 misfolding: A solution to the spondyloarthropathy conundrum?. Molecular Medicine Today 6(6): 224-230, June

HLA-B27 polymorphism in the Malays. Tissue Antigens 62(4): 330-332, October

HLA-B27 subtypes and HLA class II alleles in Japanese patients with anterior uveitis. Investigative Ophthalmology & Visual Science 40(8): 1838-1844

HLA-B27 subtypes and spondyloarthropathies. Pathologie Biologie 46(10): 737-740, Dec

HLA-B27 subtypes determination in patients with ankylosing spondylitis from Zulia, Venezuela. Human Immunology 64(7): 745-749, July

HLA-B27 subtypes differentially associated with disease exhibit subtle structural alterations. Journal of Biological Chemistry 277(49): 47844-47853

HLA-B27 subtypes in Croatian patients with ankylosing spondylitis. Scandinavian Journal of Rheumatology 30(1): 51-52

HLA-B27 transgenic mice are susceptible to collagen-induced arthritis: Type II collagen as a potential target in human disease. Human Immunology 61(2): 140-147, Feb

HLA-B27 transgenic rats are susceptible to accelerated alveolar bone loss. Journal of Periodontology 71(9): 1395-1400

HLA-B27 typing in the categorisation of uveitis in a HLA-B27 rich population. British Journal of Ophthalmology 84(4): 413-416

HLA-B27+ anterior uveitis with or without associated spondyloarthritis: clinical and immunological features. Annals of the Rheumatic Diseases 58(11): 721-722

HLA-B27-transfected (Salmonella permissive) and HLA-A2-transfected (Salmonella nonpermissive) human monocytic U937 cells differ in their production of cytokines. Infection and Immunity 70(3): 1609-1614

HLA-B35 frequency variations correlate with malaria infection in Sardinia. Tissue Antigens 52(5): 452-461

HLA-B44 subtyping in the Catalan population using reference strand mediated conformation analysis. Implications for the selection of unrelated bone marrow donors. Tissue Antigens 56(2): 173-177, August

HLA-B57-restricted cytotoxic T-lymphocyte activity in a single infected subject toward two optimal epitopes, one of which is entirely contained within the other. Journal of Virology 74(11): 5291-5299

HLA-B7 beta-pleated sheet-derived synthetic peptides are immunodominant T-cell epitopes regulating alloresponses. Blood 99(9): 3286-3292

HLA-B8 and HLA-A3 coexpressed with HLA-B8 are associated with a reduced risk of the development of chronic myeloid leukemia. Blood 93(11): 3863-3865, June 1

HLA-C allele recognition using DNA sequencing. Pathologie-Biologie 47(8): 812-818

HLA-C and guttate psoriasis. British Journal of Dermatology 143(6): 1177-1182, December

HLA-C expression on platelets: Studies with an HLA-Cw1-specific human monoclonal antibody. Vox Sanguinis 79(2): 108-111, September

HLA-C locus alleles in patients with psoriatic arthritis (PsA). Human Immunology 60(3): 259-261

HLA-C mismatches induce strong cytotoxic T-cell reactivity in the presence of an additional DRB/DQB mismatch and affect NK cell-mediated alloreactivity. Transplantation 72(5): 923-929

HLA-Cw*04 and hepatitis C virus persistence. Journal of Virology 76(10): 4792-4797

HLA-Cw*1404: A new HLA-C allele with a hybrid 77Asn-80Asn NK motif. Immunogenetics 51(7): 610-612

HLA-Cw*1701 is associated with two sub-Saharan African-derived HLA haplotypes: HLA-B*4201, DRB1*03 and HLA-B*4202 without DRB1*03. Tissue Antigens 54(3): 303-306, Sept

HLA-Cw6 specificity and polymorphic residues are associated with susceptibility among Chinese psoriatics in Taiwan. Archives of Dermatological Research 294(5): 214-220

HLA-Cw6-positive and HLA-Cw6-negative patients with Psoriasis vulgaris have distinct clinical features. Journal of Investigative Dermatology 118(2): 362-365

HLA-Cw7 zygosity affects the size of a subset of CD158b+ natural killer cells. Journal of Clinical Immunology 22(1): 28-36, January

HLA-DM and invariant chain are expressed by thyroid follicular cells, enabling the expression of compact DR molecules. International Immunology 11(2): 269-277

HLA-DM and the MHC class II antigen presentation pathway. Immunologic Research 20(3): 195-205, Dec

HLA-DM can partially replace the invariant chain for HLA-DR transport and surface expression in transfected endocrine epithelial cells. Tissue Antigens 53(5): 447-458, May

HLA-DM is expressed on the cell surface and colocalizes with HLA-DR and invariant chain in human Langerhans cell. Archives of Dermatological Research 290(12): 674-680, Dec

HLA-DM recognizes the flexible conformation of major histocompatibility complex class II. Journal of Experimental Medicine 192(12): 1697-1706, December 18

HLA-DMA allele polymorphism: No impact on kidney allograft outcome. Human Immunology 61(3): 345-347, March

HLA-DMA alleles are possible new markers of rheumatoid arthritis: study of a Corsican group. Experimental and Clinical Immunogenetics 16(4): 192-198

HLA-DMA and HLA-DMB alleles in German patients with type 1 diabetes mellitus. Tissue Antigens 54(3): 291-294, Sept

HLA-DMA and HLA-DMB genotyping in patients with rheumatic diseases. Kaohsiung Journal of Medical Sciences 15(5): 263-267

HLA-DMA and HLA-DMB genotyping in patients with systemic lupus erythematosus. Journal of Rheumatology 26(9): 1930-1933

HLA-DMB expression by thyrocytes: Indication of the antigen-processing and possible presenting capability of thyroid cells. Clinical & Experimental Immunology 116(1): 62-69, April

HLA-DMB gene and HLA-DRA promoter region polymorphisms in Australian multiple sclerosis patients. Human Immunology 60(9): 886-893, Sept

HLA-DP molecules bind cobalt: A possible explanation for the genetic association with hard metal disease. European Journal of Immunology 29(7): 2140-2147, July

HLA-DP-unrestricted TNF-alpha release in beryllium-stimulated peripheral blood mononuclear cells. European Respiratory Journal 20(5): 1174-1178

HLA-DP4, the most frequent HLA II molecule, defines a new supertype of peptide-binding specificity. Journal of Immunology 169(12): 6928-6934

HLA-DPA1 and DPB1 polymorphism in four Pacific Islands populations determined by sequencing based typing. Tissue Antigens 57(6): 493-501, June

HLA-DPB1 alleles association of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Lupus 12(7): 560-563

HLA-DPB1 alleles in house dust mite allergic patients. European Journal of Immunogenetics 26(4): 281-284, Aug

HLA-DPB1 and chronic beryllium disease: a HuGE review. American Journal of Epidemiology 157(5): 388-398

HLA-DPB1 typing by polymerase chain reaction amplification with sequence-specific primers. Tissue Antigens 57(4): 287-299, April

HLA-DPB1*0401 is associated with dominant protection against type 1 diabetes in the general Saudi population and in subjects with a high-risk DR/DQ haplotype. European Journal of Immunogenetics 30(2): 115-119, April

HLA-DQ alleles and human papillomavirus DNA in adult-onset laryngeal papillomatosis. Journal of Infectious Diseases 179(3): 682-685

HLA-DQ alleles in patients with celiac disease in Turkey. Tissue Antigens 57(6): 540-542, June

HLA-DQ and DRB1 polymorphism and susceptibility to type 1 diabetes in Jamaica. European Journal of Immunogenetics 29(1): 47-52, February

HLA-DQ determines the response to exogenous wheat proteins: a model of gluten sensitivity in transgenic knockout mice. Journal of Immunology 169(10): 5595-5600

HLA-DQ genotypes in classic type 1 diabetes and in latent autoimmune diabetes of the adult. American Journal of Epidemiology 156(9): 787-796

HLA-DQ polymorphism influences progression of demyelination and neurologic deficits in a viral model of multiple sclerosis. Molecular and Cellular Neurosciences 15(6): 495-509

HLA-DQ polymorphisms modify the risk of thyroid autoimmunity in children with type 1 diabetes mellitus. Journal of Pediatric Endocrinology & Metabolism 16(6): 851-858

HLA-DQ typing in the diagnosis of celiac disease. American Journal of Gastroenterology 97(3): 695-699, March

HLA-DQ-associated predisposition to and dominant HLA-DR-associated protection against rheumatoid arthritis. Human Immunology 60(2): 152-158, Feb

HLA-DQ1 associated with reflex sympathetic dystrophy. Neurology 53(6): 1350-1351

HLA-DQ6 transgenic mice resistance to experimental autoimmune myasthenia gravis is linked to reduced acetylcholine receptor-specific IFN-gamma, IL-2 and IL-10 production. Journal of Autoimmunity 17(3): 175-180

HLA-DQ6-mediated protection in IDDM. Human Immunology 61(2): 148-153, Feb

HLA-DQ8 and the HLA-DQ8-DR4 haplotype are positively associated with the hevein-specific IgE immune response in health care workers with latex allergy. Journal of Allergy & Clinical Immunology 110(3): 507-514, September

HLA-DQ8 as an Ir gene in coeliac disease. Gut 52(1): 7-8

HLA-DQ8 transgenic and NOD mice recognize different epitopes within the cytoplasmic region of the tyrosine phosphatase-like molecule, IA-2. Human Immunology 62(10): 1099-1105, October

HLA-DQA1 allele typing by nonisotopic PCR-LIS-SSCP. Brazilian Journal of Medical and Biological Research 34(7): 867-869

HLA-DQA1 alleles and the presence of Helicobacter pylori antibodies. European Journal of Immunogenetics 26(1): 15-17, Feb

HLA-DQA1 and -DQB1 genes and Helicobacter pylori infection in Italian patients with gastric adenocarcinoma. Tissue Antigens 59(1): 55-57, January

HLA-DQA1 and DQB1 genotyping by PCR-SSP technique in Guangxi Zhuang Chinese. Zhonghua Weishengwuxue He Mianyixue Zazhi 19(6): 504-505, Nov

HLA-DQA1 and HLA-DQB1 genetic markers and clinical presentation in celiac disease. Journal of Pediatric Gastroenterology and Nutrition 34(5): 548-554

HLA-DQA1 gene polymorphism in idiopathic dilated cardiomyopathy. Zhonghua Xinxueguanbing Zazhi 30(8): 477-479, August

HLA-DQA1 genotyping by polymerase chain reaction-single-strand conformation polymorphism (PCR-SSCP) and restriction endonuclease digestion in Papua New Guinea. Papua New Guinea Medical Journal 42(3-4): 114-123

HLA-DQA1 polymorphism in autochthonous Basques from Navarre (Spain): Genetic position within European and Mediterranean scopes. Tissue Antigens 61(6): 465-474

HLA-DQA1*0301-associated susceptibility for autoimmune polyglandular syndrome type II and III. Hormone and Metabolic Research 35(2): 120-124

HLA-DQA1*0501 is associated with diffuse systemic sclerosis in Caucasian men. Arthritis and Rheumatism 43(9): 2005-2010

HLA-DQB1 alleles and susceptibility to cervical squamous cell carcinoma in southern Iranian patients. Pathology and Oncology Research 8(1): 58-61

HLA-DQB1 alleles in Italian patients with mucous membrane pemphigoid predominantly affecting the oral cavity. British Journal of Dermatology 145(5): 805-808, November

HLA-DQB1 and HLA-DPB1 genotypes in severe preeclampsia. Obstetrics & Gynecology 96(3): 385-389, September

HLA-DQB1 genotyping with simple automated DNA sequencing and single-strand conformation polymorphism analysis. Journal of the Formosan Medical Association 99(9): 698-703

HLA-DQB1*0201: a marker for good prognosis in British and Dutch patients with sarcoidosis. American Journal of Respiratory Cell and Molecular Biology 27(4): 406-412

HLA-DQB1*0601 is primarily associated with the susceptibility to cardiac sarcoidosis. Tissue Antigens 56(1): 52-57, July

HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry 72(2): 184-187

HLA-DR and -DQ associations with insulin-dependent diabetes mellitus in a population of Turkey. Human Immunology 61(3): 296-302, March

HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis. Gut 45(3): 395-401

HLA-DR and -DQ polymorphism in Cameroon. Tissue Antigens 58(1): 1-8, July

HLA-DR and DQB1 gene polymorphism in the north-western Colombian population. Tissue Antigens 59(5): 436-439, May

HLA-DR and HLA-DQ gene typing of infertile women possessing sperm-immobilizing antibody. Journal of Reproductive Immunology 46(1): 31-38, Feb

HLA-DR and HLA-DQ polymorphism in human thyroglobulin-induced autoimmune thyroiditis: DR3 and DQ8 transgenic mice are susceptible. Human Immunology 63(4): 301-310, April

HLA-DR and HLA-DQ typing: A comparative study using serology and restriction fragment length polymorphism (RFLP) analysis. Medicina (Ribeirao Preto) 33(1): 27-31

HLA-DR antigen and HLA-DRB1 genotyping with nonobstructive azoospermia in Japan. Journal of Andrology 20(4): 545-550, July-Aug

HLA-DR antigen expression in squamous epithelial dysplasia and squamous cell carcinoma of the esophagus: an immunohistochemical study. Oncology Reports 6(2): 301-306

HLA-DR antigens in patients with pulmonary tuberculosis in northern Poland. Preliminary report. Archivum Immunologiae et Therapiae Experimentalis 48(1): 47-50

HLA-DR expression in acute pancreatitis. European Journal of Surgery 165(10): 947-951

HLA-DR expression in conjunctival cells after latanoprost. Journal of Ocular Pharmacology and Therapeutics 18(1): 1-9

HLA-DR expression is a significant prognostic factor in laryngeal cancer. APMIS 107(4): 383-388, April

HLA-DR expression of synovium and correlation with clinical features of patients with rheumatoid arthritis. Tohoku Journal of Experimental Medicine 190(3): 177-184

HLA-DR expression on lymphocyte subsets as a marker of disease activity in patients with systemic lupus erythematosus. Clinical & Experimental Immunology 125(3): 485-491, September

HLA-DR in couples associated with preeclampsia: Background and updating by DNA sequencing. Journal of Reproductive Immunology 59(2): 235-243, August

HLA-DR inhibits granulocytic differentiation without inducing apoptosis of CD34 cells. Human Immunology 60(10): 944-954, Oct

HLA-DR matched transfusions: development of donor-specific T- and B-cell antibodies and renal allograft outcome. Transplantation 67(7): 1029-1035

HLA-DR mediated cell death is associated with, but not induced by TNF-alpha secretion in APC. Human Immunology 62(2): 106-112

HLA-DR polymorphism influences T-cell precursor frequencies to Epstein-Barr virus (EBV) gp110: Implications for the association of HLA-DR antigens with rheumatoid arthritis. Tissue Antigens 54(2): 146-152

HLA-DR, DQ nucleotide sequence polymorphisms in the Pasiegos (Pas valleys, Northern Spain) and comparison of the allelic and haplotypic frequencies with those of other European populations. Tissue Antigens 53(1): 65-73

HLA-DR, HLA-DQ, and TAP genes in familial Hodgkin disease. Blood 99(2): 690-693

HLA-DR-DQ alleles and HLA-DP alleles are independently associated with susceptibility to different stages of post-schistosomal hepatic fibrosis in the Chinese population. Tissue Antigens 53(3): 269-274, March

HLA-DR/DQ haplotype in rheumatoid arthritis: novel allelic associations in UK Caucasians. Journal of Rheumatology 29(9): 1821-1826

HLA-DR/DQ interaction in patients with erosive rheumatoid arthritis presenting articular and extraarticular disease manifestations. European Journal of Immunogenetics 26(1): 19-27, Feb

HLA-DR1 (DRB1*0101) and DR4 (DRB1*0401) use the same anchor residues for binding an immunodominant peptide derived from human type II collagen. Journal of Immunology 168(1): 253-259

HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome. Blood 100(5): 1570-1574

HLA-DR15 is associated with lower age at onset in multiple sclerosis. Annals of Neurology 48(2): 211-219, August

HLA-DR2-associated DRB1 and DRB5 alleles and haplotypes in Koreans. Human Immunology 61(9): 937-941, September

Hla-DR2-restricted responses to proteolipid protein 95-116 peptide cause autoimmune encephalitis in transgenic mice. Journal of Clinical Investigation 105(7): 977-984

HLA-DR3 and DR4 and their relation to the incidence progression of diabetic retinopathy. Ophthalmology 109(2): 275-281, February

HLA-DR4 allele frequencies on Indian and Mestizo population from Mexico. Human Immunology 61(3): 341-344, March

HLA-DR4 and salivary immunoglobulin A reactions to oral streptococci. Oral Microbiology & Immunology 16(1): 45-53, February

HLA-DR4 and the spondyloarthopathies. Annals of the Rheumatic Diseases 61(3): 193-194

HLA-DR4 influences glial activity in Alzheimer's disease hippocampus. Journal of the Neurological Sciences 161(1): 66-69, Nov 26

HLA-DR4 molecules in neuroendocrine epithelial cells associate to a heterogeneous repertoire of cytoplasmic and surface self peptides. Journal of Immunology 169(9): 5052-5060

HLA-DR51 expression failure caused by a two-base deletion at exon 2 of a DRB5 null allele (DRB5*0110N) in a Spanish gypsy family. Tissue Antigens 55(5): 467-469

HLA-DR53 molecules are associated with susceptibility to celiac disease and selectively bind gliadin-derived peptides. Immunogenetics 49(9): 800-807, Aug

HLA-DR53 molecules restrict glutamic acid decarboxylase peptide presentation to T cells of a Type I diabetes patient: specification of the trimolecular HLA-peptide/T-cell receptor complex. Diabetologia 44(1): 70-80

HLA-DRB 1 alleles and the susceptibility of Iranian patients with breast cancer. Pathology and Oncology Research 7(1): 39-41

HLA-DRB alleles and systemic lupus erythematosus in Jamaicans. Southern Medical Journal 95(7): 717-719

HLA-DRB and -DQB1 polymorphism in the Macedonian population. Tissue Antigens 55(1): 53-56, Jan

HLA-DRB and HLA-DQB loci in the genetic susceptibility to develop glaucoma in Mexicans. American Journal of Ophthalmology 128(3): 297-300, Sept

HLA-DRB fluorotyping by dark quenching and automated analysis. Tissue Antigens 58(4): 250-254

HLA-DRB genotypes in Japanese patients with renal cell carcinoma. Oncology 59(1): 57-62

HLA-DRB genotyping in Gilles de la Tourette patients and their parents. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 119b(1): 60-64

HLA-DRB1 DNA sequencing based typing: An approach suitable for high throughput typing including unrelated bone marrow registry donors. Tissue Antigens 57(1): 46-54, January

HLA-DRB1 alleles and shared amino acid sequences in disease susceptibility and severity in patients from eastern France with rheumatoid arthritis. Journal of Rheumatology 26(7): 1446-1451

HLA-DRB1 alleles associated with polymyalgia rheumatica in northern Italy: correlation with disease severity. Annals of the Rheumatic Diseases 58(5): 303-308

HLA-DRB1 alleles associated with susceptibility or resistance to rheumatoid arthritis, articular deformities, and disability in Mexican Americans. Arthritis and Rheumatism 42(7): 1329-1338

HLA-DRB1 alleles encoding an aspartic acid at position 70 protect against development of rheumatoid arthritis. Journal of Rheumatology 28(2): 232-239

HLA-DRB1 alleles in Kuwaiti children with idiopathic nephrotic syndrome. Pediatric Nephrology 15(1-2): 79-81, November

HLA-DRB1 alleles in patients with vitiligo in Northern China. Zhonghua Pifuke Zazhi 33(1): 5-7, Feb

HLA-DRB1 and DQB1 genes in anticentromere antibody positive patients with SSc and primary biliary cirrhosis. Annals of the Rheumatic Diseases 60(6): 639-640

HLA-DRB1 and DQB1 genotypes in patients with insulin-dependent neonatal diabetes mellitus. A study of 13 cases. Tissue Antigens 56(3): 217-222, September

HLA-DRB1 and DQB1 polymorphisms in southern France and genetic relationships with other Mediterranean populations. Human Immunology 61(9): 930-936, September

HLA-DRB1 and HLA-DQB1 polymorphisms in Pacific Islands populations. Tissue Antigens 59(5): 397-406, May

HLA-DRB1 and MHC class 1 chain-related A haplotypes in Basque families with celiac disease. Tissue Antigens 60(1): 71-76, July

HLA-DRB1 and disease outcome in multiple sclerosis. Journal of Neurology 248(4): 304-310, April

HLA-DRB1 antigens in Taiwanese patients with juvenile-onset systemic lupus erythematosus. Rheumatology International 21(3): 103-105, November

HLA-DRB1 gene polymorphism of Naxi ethnic group of Yunnan Province, China and its ethnological evolution analysis. Acta Genetica Sinica 28(12): 1107-1115

HLA-DRB1 gene transcripts in rheumatoid arthritis. Clinical & Experimental Immunology 124(1): 142-149, April

HLA-DRB1 genes and patients with late onset rheumatoid arthritis. Annals of the Rheumatic Diseases 60(5): 531-533

HLA-DRB1 genes, rheumatoid factor, and elevated C-reactive protein: Independent risk factors of radiographic progression in early rheumatoid arthritis. Journal of Rheumatology 27(9): 2100-2109, September

HLA-DRB1 genotype influences risk for and severity of rheumatoid arthritis. Journal of Rheumatology 26(5): 1024-1034

HLA-DRB1 leprogenic motifs in Nigerian population groups. Clinical & Experimental Immunology 118(1): 56-62, Oct

HLA-DRB1 polymorphisms and autoimmune responses to desmogleins in Japanese patients with pemphigus. Tissue Antigens 54(4): 333-340

HLA-DRB1 status affects endothelial function in treated patients with rheumatoid arthritis. American Journal of Medicine 114(8): 647-652, June 1

HLA-DRB1* and allergy to Parietaria: Linkage and association analyses. Human Immunology 60(12): 1250-1258, Dec

HLA-DRB1* intron-primed sequencing for haploid genotyping. Clinical Chemistry 49(4): 692-694

HLA-DRB1*, -DQB1* in Piramalai Kallars and Yadhavas, two Dravidian-speaking castes of Tamil Nadu, South India. Tissue Antigens 61(6): 451-464, June

HLA-DRB1*01 alleles are associated with sensitization to cockroach allergens. Journal of Allergy and Clinical Immunology 105(5): 960-966

HLA-DRB1*01 and DRB1*04 alleles in Sardinian rheumatoid arthritis patients. Tissue Antigens 53(1): 97-100, Jan

HLA-DRB1*03 and DQB1*0302 associations in a subset of patients severely affected with systemic lupus erythematosus from western India. Annals of the Rheumatic Diseases 62(1): 92-93

HLA-DRB1*03, DRB1*11 or DRB1*12 and their respective DRB3 specificities in clinical variants of sarcoidosis. Tissue Antigens 57(1): 87-90, January

HLA-DRB1*04 alleles in psoriatic arthritis: Comparison with rheumatoid arthritis and healthy controls. Human Immunology 62(11): 1239-1244, November

HLA-DRB1*04 and susceptibility to type 1 diabetes mellitus in a German/Belgian family and German case-control study. Tissue Antigens 55(3): 271-274, March

HLA-DRB1*0403 is associated with dominant protection against IDDM in the general Dutch population and subjects with high-risk DQA1*0301-DQB1*0302/DQA1*0501-DQB1*0201 genotype. Tissue Antigens 54(1): 88-90, July

HLA-DRB1*0701 and DRB1*1401 are associated with genetic susceptibility to psoriasis vulgaris in a Taiwanese population. British Journal of Dermatology 139(6): 978-983, Dec

HLA-DRB1*08, DRB1*03/DRB3*0101, and DRB3*0202 are susceptibility genes for Graves' disease in North American Caucasians, whereas DRB1*07 is protective. Journal of Clinical Endocrinology and Metabolism 84(9): 3182-3186

HLA-DRB1*12 is associated with protection against complicated typhoid fever, independent of tumour necrosis factor alpha. European Journal of Immunogenetics 29(4): 297-300

HLA-DRB1*15 and pediatric aplastic anemia. Haematologica 87(7): 772-774

HLA-DRB1*1501 and response to copolymer-1 therapy in relapsing-remitting multiple sclerosis. Neurology 57(11): 1976-1979

HLA-DRB1*1502 confers susceptibility to ulcerative colitis, but is negatively associated with its intractability: a Korean study. International Journal of Colorectal Disease 17(4): 233-237

HLA-DRB1*16-restricted recognition of myeloid cells, including CD34+ CML progenitor cells. British Journal of Haematology 121(5): 721-729, June

HLA-DRB1*1602 allele is positively associated with HPV cervical infection in Bolivian Andean women. Human Immunology 64(9): 890-895, September

HLA-DRB1, -DQA1, -DQB1 and DPB1 susceptibility alleles in Cameroonian type 1 diabetes patients and controls. European Journal of Immunogenetics 28(4): 459-462, August

HLA-DRB1, DQA1, and DQB1 alleles associated with giant cell arteritis in northern Italy. Journal of Rheumatology 26(11): 2395-2399

HLA-DRB1, DQB1 and DPB1 polymorphism in the Naxi ethnic group of South-western China. Tissue Antigens 61(2): 179-183, February

HLA-DRB1,3,4,5 and -DQB1 allele frequencies and HLA-DR/DQ linkage disequilibrium of 231 German caucasoid patients and their corresponding 821 potential unrelated stem cell transplants. Human Immunology 61(6): 605-614, June

HLA-DRB3 *0101 is associated with Graves' disease in Jamaicans. Clinical Endocrinology 55(6): 805-808, December

HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells. European Journal of Immunology 30(6): 1623-1631

HLA-E polymorphism in patients with recurrent spontaneous abortion. Tissue Antigens 52(6): 569-572, Dec

HLA-E-dependent presentation of Mtb-derived antigen to human CD8+ T cells. Journal of Experimental Medicine 196(11): 1473-1481

HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics 55(2): 63-79

HLA-G and HLA-E polymorphisms in an indigenous African population. Human Immunology 61(11): 1150-1156, November

HLA-G and MIC expression in tumors and their role in anti-tumor immunity. Trends in Immunology 24(2): 82-87, February

HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells?. American Journal of Pathology 159(1): 71-77

HLA-G and classical HLA class I transcripts in various components of the adult human eye. European Journal of Immunogenetics 26(4): 271-274, Aug

HLA-G and its KIR ligands in cancer: Another enigma yet to be solved?. Journal of Pathology 196(3): 252-253, March

HLA-G does not have a pathophysiological role in Graves' disease. Journal of Clinical Pathology 56(6): 475-477

HLA-G exhibits low level of polymorphism in indigenous East Africans. Human Immunology 63(6): 495-501, June

HLA-G expression by tumors. American Journal of Reproductive Immunology 45(2): 103-107, February

HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy. European Journal of Immunology 32(2): 311-315, February

HLA-G expression in human melanoma cells: Protection from NK cytolysis. Journal of Reproductive Immunology 43(2): 183-193, July

HLA-G expression in trophoblast cells circulating in maternal peripheral blood during early pregnancy. American Journal of Obstetrics and Gynecology 184(5): 991-997

HLA-G expression in trophoblast cells is independent of embryonic development. Human Immunology 61(11): 1108-1112, November

HLA-G expression protects porcine endothelial cells against natural killer cell-mediated xenogeneic cytotoxicity. Transplantation 67(1): 31-37

HLA-G has a concentration-dependent effect on the generation of an allo-CTL response. Immunology 101(2): 191-200, October

HLA-G immunoreactivity is specific for intermediate trophoblast in gestational trophoblastic disease and can serve as a useful marker in differential diagnosis. American Journal of Surgical Pathology 26(7): 914-920

HLA-G in melanoma: A new strategy to escape from immunosurveillance?. Onkologie 25(2): 129-134

HLA-G in reproduction: Studies on the maternal-fetal interface. Human Immunology 61(11): 1113-1117, November

HLA-G in the human thymus: a subpopulation of medullary epithelial but not CD83(+) dendritic cells expresses HLA-G as a membrane-bound and soluble protein. International Immunology 11(6): 889-898

HLA-G inhibits the allogeneic proliferative response. Journal of Reproductive Immunology 43(2): 203-211, July

HLA-G inhibits the functions of murine dendritic cells via the PIR-B immune inhibitory receptor. European Journal of Immunology 32(9): 2418-2426

HLA-G inhibits the transendothelial migration of human NK cells. European Journal of Immunology 30(2): 586-593

HLA-G polymorphisms in couples with recurrent spontaneous abortions. Tissue Antigens 60(2): 122-132, August

HLA-G promotes immune tolerance. Journal of Biological Regulators and Homeostatic Agents 14(2): 93-98